group_id,max_val,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_00043,0.6139529465111517,FUN_000270-T1,Peve_00027796,Pocillopora_meandrina_HIv1___RNAseq.g28983.t1,three_way,78.31466666666667,FUN_000270-T1,Q0P483,S2542_DANRE,,Mitochondrial coenzyme A transporter SLC25A42 (Solute carrier family 25 member 42),Danio rerio (Zebrafish) (Brachydanio rerio),51.5,324.0,5.3e-87,322.8,sp|Q0P483|S2542_DANRE Mitochondrial coenzyme A transporter SLC25A42 OS=Danio rerio OX=7955 GN=slc25a42 PE=2 SV=1,GO:0005347; GO:0005739; GO:0005743; GO:0007006; GO:0015217; GO:0015228; GO:0015866; GO:0015867; GO:0035349; GO:0043262; GO:0080121; GO:0080122,ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349]; mitochondrial membrane organization [GO:0007006],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ADP phosphatase activity [GO:0043262]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228],GO:0003824; GO:0005215; GO:0005739; GO:0007005; GO:0016787; GO:0043226; GO:0055085; GO:0061024,catalytic activity; transporter activity; mitochondrion; mitochondrion organization; hydrolase activity; organelle; transmembrane transport; membrane organization
OG_00126,0.3645873958017488,FUN_000550-T1,Peve_00039823,Pocillopora_meandrina_HIv1___RNAseq.g2362.t1,three_way,66.874,FUN_000550-T1,Q923Y6,,,,,23.8,332.0,7.3e-11,69.7,sp|Q923Y6|TAAR9_RAT Trace amine-associated receptor 9 OS=Rattus norvegicus OX=10116 GN=Taar9 PE=2 SV=1,,,,,,
OG_00203,0.4337694599396806,FUN_000918-T1,Peve_00044972,Pocillopora_meandrina_HIv1___RNAseq.g29483.t1,three_way,64.11866666666667,,,,,,,,,,,,,,,,,
OG_00225,0.51609133551913,FUN_000960-T1,Peve_00021379,Pocillopora_meandrina_HIv1___RNAseq.13437_t,three_way,86.795,FUN_000960-T1,P28271,ACOHC_MOUSE,,Cytoplasmic aconitate hydratase (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1),Mus musculus (Mouse),71.1,869.0,0.0,1303.1,sp|P28271|ACOHC_MOUSE Cytoplasmic aconitate hydratase OS=Mus musculus OX=10090 GN=Aco1 PE=1 SV=3,GO:0003994; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006099; GO:0006101; GO:0006417; GO:0006740; GO:0006879; GO:0009791; GO:0010040; GO:0010468; GO:0030350; GO:0046872; GO:0050892; GO:0051538; GO:0051539,citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; intracellular iron ion homeostasis [GO:0006879]; NADPH regeneration [GO:0006740]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739],"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]",GO:0003723; GO:0003824; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006091; GO:0016829; GO:0022600; GO:0043226; GO:0055086,RNA binding; catalytic activity; mitochondrion; endoplasmic reticulum; Golgi apparatus; cytosol; generation of precursor metabolites and energy; lyase activity; digestive system process; organelle; nucleobase-containing small molecule metabolic process
OG_00323,0.6002214730483052,FUN_001142-T1,Peve_00029340,Pocillopora_meandrina_HIv1___RNAseq.g29332.t1,three_way,72.95883333333333,FUN_001142-T1,Q91827,,,,,38.8,178.0,1.4999999999999998e-24,114.4,sp|Q91827|AR1_XENLA Apoptosis regulator R1 (Fragment) OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_00343,0.2229205132642489,FUN_001168-T1,Peve_00015997,Pocillopora_meandrina_HIv1___RNAseq.g29153.t1,three_way,86.27633333333334,FUN_001168-T1,A4IJ21,,,,,52.2,255.0,2.3e-13,78.6,sp|A4IJ21|MNS1_XENTR Meiosis-specific nuclear structural protein 1 OS=Xenopus tropicalis OX=8364 GN=mns1 PE=2 SV=1,,,,,,
OG_00474,0.5606424718655311,FUN_001413-T1,Peve_00008749,Pocillopora_meandrina_HIv1___RNAseq.g2101.t1,three_way,46.56633333333333,,,,,,,,,,,,,,,,,
OG_00657,0.2051789066927331,FUN_001944-T1,Peve_00030386,Pocillopora_meandrina_HIv1___RNAseq.g29312.t1,three_way,71.12366666666667,FUN_001944-T1,Q5QNP2,TA13C_DANRE,,Trace amine-associated receptor 13c,Danio rerio (Zebrafish) (Brachydanio rerio),30.0,297.0,2.8e-12,74.3,sp|Q5QNP2|TA13C_DANRE Trace amine-associated receptor 13c OS=Danio rerio OX=7955 GN=taar13c PE=1 SV=1,GO:0001594; GO:0004984; GO:0005886; GO:0007186; GO:0007606; GO:0008227; GO:0009995; GO:0016020; GO:0019808; GO:0019810; GO:0050911; GO:1990834,detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; response to odorant [GO:1990834]; sensory perception of chemical stimulus [GO:0007606]; soluble molecule recognition [GO:0009995],membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled amine receptor activity [GO:0008227]; olfactory receptor activity [GO:0004984]; polyamine binding [GO:0019808]; putrescine binding [GO:0019810]; trace-amine receptor activity [GO:0001594],GO:0005886; GO:0050877; GO:0060089,plasma membrane; nervous system process; molecular transducer activity
OG_00661,0.5065630782836216,FUN_001954-T1,Peve_00024484,Pocillopora_meandrina_HIv1___RNAseq.g29228.t1,three_way,86.64866666666667,FUN_001954-T1,Q6FIF0,ZFAN6_HUMAN,,AN1-type zinc finger protein 6 (Associated with PRK1 protein) (Zinc finger A20 domain-containing protein 3),Homo sapiens (Human),38.9,208.0,1.9e-29,130.6,sp|Q6FIF0|ZFAN6_HUMAN AN1-type zinc finger protein 6 OS=Homo sapiens OX=9606 GN=ZFAND6 PE=1 SV=2,GO:0003677; GO:0005829; GO:0006625; GO:0006915; GO:0008270; GO:0015031; GO:0031593; GO:0043066; GO:0043122; GO:0071356,apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; protein targeting to peroxisome [GO:0006625]; protein transport [GO:0015031]; regulation of canonical NF-kappaB signal transduction [GO:0043122],cytosol [GO:0005829],DNA binding [GO:0003677]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270],GO:0003677; GO:0005829; GO:0012501,DNA binding; cytosol; programmed cell death
OG_00688,0.06496838378432,FUN_002360-T1,Peve_00029564,Pocillopora_meandrina_HIv1___RNAseq.g51.t1,three_way,43.132333333333335,,,,,,,,,,,,,,,,,
OG_00712,0.3297032635928228,FUN_002580-T1,Peve_00025541,Pocillopora_meandrina_HIv1___TS.g9163.t1,three_way,57.59933333333333,FUN_002580-T1,Q6AZD4,,,,,48.1,160.0,1.2e-45,186.4,sp|Q6AZD4|IMP2L_DANRE Mitochondrial inner membrane protease subunit 2 OS=Danio rerio OX=7955 GN=immp2l PE=2 SV=1,,,,,,
OG_00764,0.6107831489038036,FUN_003433-T1,Peve_00010310,Pocillopora_meandrina_HIv1___RNAseq.g9161.t1,three_way,48.00683333333333,,,,,,,,,,,,,,,,,
OG_00789,0.1303181645373886,FUN_003934-T1,Peve_00006586,Pocillopora_meandrina_HIv1___RNAseq.g11751.t1,three_way,62.47316666666666,FUN_003934-T1,Q60847,COCA1_MOUSE,,Collagen alpha-1(XII) chain,Mus musculus (Mouse),34.2,184.0,3e-23,113.2,sp|Q60847|COCA1_MOUSE Collagen alpha-1(XII) chain OS=Mus musculus OX=10090 GN=Col12a1 PE=2 SV=3,GO:0005581; GO:0005615; GO:0007155; GO:0035987; GO:0062023,cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],,GO:0005615; GO:0007155; GO:0030154,extracellular space; cell adhesion; cell differentiation
OG_00865,0.2374252190198229,FUN_004131-T1,Peve_00009433,Pocillopora_meandrina_HIv1___RNAseq.g16790.t1,three_way,49.26166666666666,,,,,,,,,,,,,,,,,
OG_00938,0.6549564727289531,FUN_004288-T1,Peve_00029197,Pocillopora_meandrina_HIv1___RNAseq.g11767.t1,three_way,35.059,,,,,,,,,,,,,,,,,
OG_00967,0.1483729567402691,FUN_004338-T1,Peve_00016481,Pocillopora_meandrina_HIv1___TS.g18411.t1,three_way,46.418,,,,,,,,,,,,,,,,,
OG_01034,0.1907777321525956,FUN_004469-T1,Peve_00007167,Pocillopora_meandrina_HIv1___RNAseq.g4952.t1,three_way,86.357,FUN_004469-T1,P14211,CALR_MOUSE,,Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP),Mus musculus (Mouse),77.3,198.0,5.6e-85,315.5,sp|P14211|CALR_MOUSE Calreticulin OS=Mus musculus OX=10090 GN=Calr PE=1 SV=1,GO:0000122; GO:0001669; GO:0001849; GO:0002502; GO:0003729; GO:0005049; GO:0005178; GO:0005506; GO:0005509; GO:0005576; GO:0005615; GO:0005635; GO:0005739; GO:0005783; GO:0005788; GO:0005790; GO:0005829; GO:0005840; GO:0006611; GO:0007283; GO:0008284; GO:0009410; GO:0009897; GO:0010595; GO:0010628; GO:0016020; GO:0017148; GO:0030246; GO:0030866; GO:0031625; GO:0032355; GO:0033018; GO:0033144; GO:0033574; GO:0034504; GO:0040020; GO:0042277; GO:0042562; GO:0042824; GO:0044183; GO:0044194; GO:0044322; GO:0045335; GO:0045665; GO:0045787; GO:0048387; GO:0048471; GO:0050681; GO:0050766; GO:0050821; GO:0051082; GO:0055007; GO:0060473; GO:0071257; GO:0071285; GO:0090398; GO:0098586; GO:0098794; GO:0098978; GO:0140313; GO:1900026; GO:1901164; GO:1901224; GO:1901652; GO:1903416; GO:1904614; GO:2000510,cardiac muscle cell differentiation [GO:0055007]; cellular response to electrical stimulus [GO:0071257]; cellular response to lithium ion [GO:0071285]; cellular response to virus [GO:0098586]; cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of meiotic nuclear division [GO:0040020]; response to biphenyl [GO:1904614]; response to estradiol [GO:0032355]; response to glycoside [GO:1903416]; response to peptide [GO:1901652]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283],acrosomal vesicle [GO:0001669]; cortical granule [GO:0060473]; cytolytic granule [GO:0044194]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynapse [GO:0098794]; ribosome [GO:0005840]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; complement component C1q complex binding [GO:0001849]; hormone binding [GO:0042562]; integrin binding [GO:0005178]; iron ion binding [GO:0005506]; molecular sequestering activity [GO:0140313]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; nuclear export signal receptor activity [GO:0005049]; peptide binding [GO:0042277]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082],GO:0003723; GO:0005576; GO:0005615; GO:0005635; GO:0005739; GO:0005764; GO:0005773; GO:0005783; GO:0005829; GO:0005840; GO:0006355; GO:0006886; GO:0006913; GO:0007010; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0044183; GO:0065003; GO:0140104; GO:0140313,RNA binding; extracellular region; extracellular space; nuclear envelope; mitochondrion; lysosome; vacuole; endoplasmic reticulum; cytosol; ribosome; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; cytoskeleton organization; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; protein folding chaperone; protein-containing complex assembly; molecular carrier activity; molecular sequestering activity
OG_01091,0.7395435824745207,FUN_004584-T1,Peve_00012393,Pocillopora_meandrina_HIv1___RNAseq.g6602.t1,three_way,49.74033333333333,,,,,,,,,,,,,,,,,
OG_01092,0.6679051872159364,FUN_004588-T1,Peve_00012396,Pocillopora_meandrina_HIv1___RNAseq.g6598.t1,three_way,60.343833333333336,,,,,,,,,,,,,,,,,
OG_01240,0.6510871133997463,FUN_004926-T1,Peve_00034769,Pocillopora_meandrina_HIv1___RNAseq.g8365.t1,three_way,75.525,,,,,,,,,,,,,,,,,
OG_01250,0.4655683092181394,FUN_004969-T1,Peve_00043270,Pocillopora_meandrina_HIv1___TS.g20136.t1,three_way,49.14716666666666,,,,,,,,,,,,,,,,,
OG_01269,0.2149530875583198,FUN_005037-T1,Peve_00016741,Pocillopora_meandrina_HIv1___RNAseq.g8314.t1,three_way,56.831,FUN_005037-T1,Q6GLK2,THEM4_XENLA,,Acyl-coenzyme A thioesterase THEM4 (Acyl-CoA thioesterase THEM4) (EC 3.1.2.2) (Thioesterase superfamily member 4),Xenopus laevis (African clawed frog),35.5,200.0,5.9e-25,116.3,sp|Q6GLK2|THEM4_XENLA Acyl-coenzyme A thioesterase THEM4 OS=Xenopus laevis OX=8355 GN=them4 PE=2 SV=2,GO:0005743; GO:0005758; GO:0006631; GO:0006915; GO:0016787; GO:0032587,apoptotic process [GO:0006915]; fatty acid metabolic process [GO:0006631],mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; ruffle membrane [GO:0032587],hydrolase activity [GO:0016787],GO:0003824; GO:0006629; GO:0012501; GO:0016787,catalytic activity; lipid metabolic process; programmed cell death; hydrolase activity
OG_01363,0.069341976834495,FUN_005306-T1,Peve_00003318,Pocillopora_meandrina_HIv1___TS.g19913.t1,three_way,62.791500000000006,FUN_005306-T1,O35598,ADA10_MOUSE,,Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c),Mus musculus (Mouse),33.5,487.0,1.4999999999999998e-68,261.9,sp|O35598|ADA10_MOUSE Disintegrin and metalloproteinase domain-containing protein 10 OS=Mus musculus OX=10090 GN=Adam10 PE=1 SV=2,GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005886; GO:0005912; GO:0006468; GO:0006509; GO:0006913; GO:0007162; GO:0007219; GO:0007220; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0014069; GO:0016485; GO:0017124; GO:0019901; GO:0030136; GO:0030307; GO:0030424; GO:0030425; GO:0034332; GO:0034612; GO:0038004; GO:0042117; GO:0042169; GO:0042803; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0062023; GO:0070573; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:0099175; GO:0140249; GO:0140448; GO:1901342; GO:1902945,adherens junction organization [GO:0034332]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; nucleocytoplasmic transport [GO:0006913]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein catabolic process at postsynapse [GO:0140249]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of postsynapse organization [GO:0099175]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; signaling receptor ligand precursor processing [GO:0140448],adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; tetraspanin-enriched microdomain [GO:0097197],endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124],GO:0002376; GO:0003824; GO:0005634; GO:0005794; GO:0005886; GO:0006913; GO:0016787; GO:0030163; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0051604; GO:0065003; GO:0140096,"immune system process; catalytic activity; nucleus; Golgi apparatus; plasma membrane; nucleocytoplasmic transport; hydrolase activity; protein catabolic process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; protein maturation; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_01371,0.313774070815862,FUN_005321-T1,Peve_00003307,Pocillopora_meandrina_HIv1___TS.g19924.t1,three_way,52.27433333333333,FUN_005321-T1,Q3UZD5,PRDM6_MOUSE,,Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle),Mus musculus (Mouse),45.8,155.0,2.6000000000000003e-32,141.0,sp|Q3UZD5|PRDM6_MOUSE Putative histone-lysine N-methyltransferase PRDM6 OS=Mus musculus OX=10090 GN=Prdm6 PE=1 SV=1,GO:0000122; GO:0005634; GO:0008270; GO:0022008; GO:0032259; GO:0042802; GO:0045892; GO:0051151; GO:0140944,methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008],nucleus [GO:0005634],histone H4K20 monomethyltransferase activity [GO:0140944]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_01469,0.2147209367575179,FUN_006006-T1,Peve_00032352,Pocillopora_meandrina_HIv1___RNAseq.g19922.t1,three_way,81.52133333333333,FUN_006006-T1,Q8BXX9,,,,,35.5,214.0,1.0999999999999998e-24,115.2,sp|Q8BXX9|CC169_MOUSE Coiled-coil domain-containing protein 169 OS=Mus musculus OX=10090 GN=Ccdc169 PE=2 SV=2,,,,,,
OG_01495,0.4200526212415459,FUN_006218-T1,Peve_00020212,Pocillopora_meandrina_HIv1___RNAseq.g20436.t1,three_way,60.865,,,,,,,,,,,,,,,,,
OG_01583,0.388346744819862,FUN_006619-T1,Peve_00040865,Pocillopora_meandrina_HIv1___RNAseq.g20179.t1,three_way,71.24033333333334,FUN_006619-T1,Q92598,HS105_HUMAN,,Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein) (Heat shock protein family H member 1),Homo sapiens (Human),51.3,686.0,5.6e-181,636.0,sp|Q92598|HS105_HUMAN Heat shock protein 105 kDa OS=Homo sapiens OX=9606 GN=HSPH1 PE=1 SV=1,GO:0000774; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006457; GO:0006986; GO:0032991; GO:0043014; GO:0045345; GO:0051085; GO:0051135; GO:0070062; GO:0071682; GO:0140662,chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662],GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006457; GO:0008092; GO:0043226; GO:0044183; GO:0098772; GO:0140657,extracellular region; nucleus; nucleoplasm; cytosol; protein folding; cytoskeletal protein binding; organelle; protein folding chaperone; molecular function regulator activity; ATP-dependent activity
OG_01592,0.3277776693962003,FUN_006632-T1,Peve_00040842,Pocillopora_meandrina_HIv1___RNAseq.g20164.t1,three_way,91.31466666666668,FUN_006632-T1,Q8IYE0,CC146_HUMAN,,Coiled-coil domain-containing protein 146,Homo sapiens (Human),47.2,932.0,2e-175,617.8,sp|Q8IYE0|CC146_HUMAN Coiled-coil domain-containing protein 146 OS=Homo sapiens OX=9606 GN=CCDC146 PE=1 SV=2,GO:0000902; GO:0005813; GO:0005814; GO:0005856; GO:0005930; GO:0006997; GO:0007286; GO:0007288; GO:0007338; GO:0008283; GO:0010467; GO:0030496; GO:0036064; GO:0036126; GO:0044877; GO:0120212; GO:0120316; GO:1905198,cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; gene expression [GO:0010467]; manchette assembly [GO:1905198]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; spermatid development [GO:0007286],axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; midbody [GO:0030496]; sperm flagellum [GO:0036126]; sperm head-tail coupling apparatus [GO:0120212],protein-containing complex binding [GO:0044877],GO:0005815; GO:0005856; GO:0005929; GO:0007010; GO:0022414; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cytoskeleton; cilium; cytoskeleton organization; reproductive process; organelle; cilium organization; anatomical structure development
OG_01594,0.3463400880834275,FUN_006636-T1,Peve_00024051,Pocillopora_meandrina_HIv1___RNAseq.g20236.t1,three_way,88.66666666666667,FUN_006636-T1,Q12756,,,,,37.3,475.0,5e-70,267.3,sp|Q12756|KIF1A_HUMAN Kinesin-like protein KIF1A OS=Homo sapiens OX=9606 GN=KIF1A PE=1 SV=2,,,,,,
OG_01613,0.2299609648519626,FUN_006702-T1,Peve_00028381,Pocillopora_meandrina_HIv1___RNAseq.g19982.t1,three_way,56.388,,,,,,,,,,,,,,,,,
OG_01700,0.2259409443731656,FUN_006943-T1,Peve_00014293,Pocillopora_meandrina_HIv1___RNAseq.g20147.t1,three_way,84.57433333333333,FUN_006943-T1,Q5RCK6,SYT10_PONAB,,Synaptotagmin-10 (Synaptotagmin X) (SytX),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),33.1,257.0,5.399999999999999e-25,116.7,sp|Q5RCK6|SYT10_PONAB Synaptotagmin-10 OS=Pongo abelii OX=9601 GN=SYT10 PE=2 SV=1,GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0007608; GO:0017156; GO:0030276; GO:0030658; GO:0042803; GO:0045956; GO:0046982; GO:0070382; GO:0098793; GO:0098978,calcium-ion regulated exocytosis [GO:0017156]; chemical synaptic transmission [GO:0007268]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; sensory perception of smell [GO:0007608],exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; transport vesicle membrane [GO:0030658],"calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]",GO:0005886; GO:0008289; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0050877,plasma membrane; lipid binding; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; nervous system process
OG_01705,0.250532669470797,FUN_006950-T1,Peve_00035084,Pocillopora_meandrina_HIv1___RNAseq.g20153.t1,three_way,71.223,FUN_006950-T1,Q502W6,VWA3B_HUMAN,,von Willebrand factor A domain-containing protein 3B (VWA domain-containing protein 3B),Homo sapiens (Human),35.3,1239.0,4.6e-206,720.7,sp|Q502W6|VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens OX=9606 GN=VWA3B PE=1 SV=3,GO:0005654; GO:0005829,,cytosol [GO:0005829]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005829,nucleoplasm; cytosol
OG_01777,0.2626292288184543,FUN_007148-T1,Peve_00028252,Pocillopora_meandrina_HIv1___RNAseq.g19712.t1,three_way,76.93933333333332,FUN_007148-T1,Q4R6T7,IQUB_MACFA,,IQ motif and ubiquitin-like domain-containing protein,Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),50.9,633.0,6.800000000000001e-178,625.9,sp|Q4R6T7|IQUB_MACFA IQ motif and ubiquitin-like domain-containing protein OS=Macaca fascicularis OX=9541 GN=IQUB PE=2 SV=2,GO:0001534; GO:0001669; GO:0007618; GO:0030317; GO:0036126; GO:0060271; GO:0097729,cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; mating [GO:0007618],9+2 motile cilium [GO:0097729]; acrosomal vesicle [GO:0001669]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0022414; GO:0031410; GO:0043226; GO:0044782; GO:0048870,cilium; microtubule-based movement; reproductive process; cytoplasmic vesicle; organelle; cilium organization; cell motility
OG_01779,0.2345479083725974,FUN_007151-T1,Peve_00028249,Pocillopora_meandrina_HIv1___RNAseq.g19715.t1,three_way,89.094,FUN_007151-T1,Q9H4K1,,,,,43.0,374.0,1.4e-71,271.6,sp|Q9H4K1|RIBC2_HUMAN RIB43A-like with coiled-coils protein 2 OS=Homo sapiens OX=9606 GN=RIBC2 PE=1 SV=2,,,,,,
OG_01868,0.5271665994113611,FUN_007834-T1,Peve_00003993,Pocillopora_meandrina_HIv1___RNAseq.g18432.t1b,three_way,72.9755,FUN_007834-T1,Q3UFK8,,,,,35.4,378.0,1.6e-61,238.4,sp|Q3UFK8|FRMD8_MOUSE FERM domain-containing protein 8 OS=Mus musculus OX=10090 GN=Frmd8 PE=1 SV=2,,,,,,
OG_01967,0.1719101548454598,FUN_008051-T1,Peve_00045153,Pocillopora_meandrina_HIv1___RNAseq.g30357.t1,three_way,45.46666666666667,,,,,,,,,,,,,,,,,
OG_02039,0.3821926849025002,FUN_008244-T1,Peve_00031788,Pocillopora_meandrina_HIv1___RNAseq.g17947.t1,three_way,64.75966666666667,FUN_008244-T1,P47747,,,,,30.3,333.0,3.8e-23,110.5,sp|P47747|HRH2_CAVPO Histamine H2 receptor OS=Cavia porcellus OX=10141 GN=HRH2 PE=3 SV=1,,,,,,
OG_02050,0.1461349736053609,FUN_008260-T1,Peve_00042074,Pocillopora_meandrina_HIv1___RNAseq.g17965.t1,three_way,81.01316666666668,FUN_008260-T1,P59325,,,,,52.8,390.0,5e-105,382.9,sp|P59325|IF5_MOUSE Eukaryotic translation initiation factor 5 OS=Mus musculus OX=10090 GN=Eif5 PE=1 SV=1,,,,,,
OG_02066,0.1608183979197782,FUN_008280-T1,Peve_00001965,Pocillopora_meandrina_HIv1___RNAseq.g17988.t1,three_way,85.35566666666666,FUN_008280-T1,A7RP64,PNO1_NEMVE,,RNA-binding protein pno1,Nematostella vectensis (Starlet sea anemone),74.9,235.0,7.3e-98,358.2,sp|A7RP64|PNO1_NEMVE RNA-binding protein pno1 OS=Nematostella vectensis OX=45351 GN=pno1 PE=3 SV=1,GO:0003723; GO:0005634; GO:0005730; GO:0032040; GO:0042274,ribosomal small subunit biogenesis [GO:0042274],nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005730; GO:0043226,RNA binding; nucleus; nucleolus; organelle
OG_02078,0.3773530498050684,FUN_008295-T1,Peve_00012967,Pocillopora_meandrina_HIv1___RNAseq.g18014.t1,three_way,51.149,,,,,,,,,,,,,,,,,
OG_02112,0.626529390517254,FUN_008397-T1,Peve_00043603,Pocillopora_meandrina_HIv1___RNAseq.g6179.t1,three_way,31.29733333333333,FUN_008397-T1,Q0P5F3,LIN7C_BOVIN,,Protein lin-7 homolog C (Lin-7C),Bos taurus (Bovine),35.4,99.0,4.4e-07,60.5,sp|Q0P5F3|LIN7C_BOVIN Protein lin-7 homolog C OS=Bos taurus OX=9913 GN=LIN7C PE=2 SV=1,GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008582; GO:0015031; GO:0016323; GO:0030674; GO:0043005; GO:0045202; GO:0048489; GO:0097025; GO:0098793; GO:0098839,exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic vesicle transport [GO:0048489],basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202],protein-macromolecule adaptor activity [GO:0030674],GO:0016192; GO:0060090,vesicle-mediated transport; molecular adaptor activity
OG_02115,0.3164649971969797,FUN_008400-T1,Peve_00043703,Pocillopora_meandrina_HIv1___TS.g24890.t1,three_way,85.94066666666667,FUN_008400-T1,O00180,KCNK1_HUMAN,,Potassium channel subfamily K member 1 (Inward rectifying potassium channel protein TWIK-1) (Potassium channel K2P1) (Potassium channel KCNO1),Homo sapiens (Human),39.4,246.0,1.8000000000000002e-44,181.4,sp|O00180|KCNK1_HUMAN Potassium channel subfamily K member 1 OS=Homo sapiens OX=9606 GN=KCNK1 PE=1 SV=1,GO:0005242; GO:0005267; GO:0005272; GO:0005886; GO:0006813; GO:0008076; GO:0014047; GO:0016020; GO:0016324; GO:0022834; GO:0022841; GO:0030425; GO:0031526; GO:0034705; GO:0035094; GO:0035725; GO:0042802; GO:0043204; GO:0043231; GO:0046982; GO:0055037; GO:0060075; GO:0071468; GO:0071805; GO:0097060; GO:1902476; GO:1902937; GO:1905030,cellular response to acidic pH [GO:0071468]; chloride transmembrane transport [GO:1902476]; glutamate secretion [GO:0014047]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075]; response to nicotine [GO:0035094]; sodium ion transmembrane transport [GO:0035725],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; inward rectifier potassium channel complex [GO:1902937]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; recycling endosome [GO:0055037]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076],identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; ligand-gated channel activity [GO:0022834]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein heterodimerization activity [GO:0046982]; sodium channel activity [GO:0005272]; voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_02141,0.2427987234740893,FUN_008447-T1,Peve_00025571,Pocillopora_meandrina_HIv1___TS.g21055.t1,three_way,82.89383333333333,FUN_008447-T1,Q8BYM7,RSH4A_MOUSE,,Radial spoke head protein 4 homolog A (Radial spoke head-like protein 3),Mus musculus (Mouse),54.9,495.0,6.1e-121,436.0,sp|Q8BYM7|RSH4A_MOUSE Radial spoke head protein 4 homolog A OS=Mus musculus OX=10090 GN=Rsph4a PE=1 SV=2,GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005930; GO:0051649; GO:0060294; GO:0062177; GO:0097729; GO:0120221; GO:0120336; GO:0120337; GO:0120338,cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; maintenance of ciliary planar beating movement pattern [GO:0120221]; radial spoke assembly [GO:0062177],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 2 [GO:0120337]; radial spoke head 3 [GO:0120338],,GO:0005576; GO:0005929; GO:0007018; GO:0043226; GO:0065003,extracellular region; cilium; microtubule-based movement; organelle; protein-containing complex assembly
OG_02177,0.1998729457692799,FUN_008528-T1,Peve_00029541,Pocillopora_meandrina_HIv1___RNAseq.g14749.t1,three_way,54.26616666666667,,,,,,,,,,,,,,,,,
OG_02213,0.1370262699786636,FUN_008598-T1,Peve_00040010,Pocillopora_meandrina_HIv1___TS.g13357.t1,three_way,50.58566666666667,,,,,,,,,,,,,,,,,
OG_02221,0.4682184102111255,FUN_008616-T2,Peve_00015392,Pocillopora_meandrina_HIv1___RNAseq.g12745.t1,three_way,74.7925,FUN_008616-T2,E7FDW2,,,,,28.2,602.0,3.1000000000000003e-57,225.3,sp|E7FDW2|PZR3B_DANRE E3 ubiquitin-protein ligase PDZRN3-B OS=Danio rerio OX=7955 GN=pdzrn3b PE=1 SV=1,,,,,,
OG_02308,0.385850289955125,FUN_008887-T1,Peve_00000779,Pocillopora_meandrina_HIv1___RNAseq.g4004.t1,three_way,73.50366666666666,FUN_008887-T1,Q0VD32,CRBL2_BOVIN,,cAMP-responsive element-binding protein-like 2,Bos taurus (Bovine),61.9,84.0,8.4e-21,101.7,sp|Q0VD32|CRBL2_BOVIN cAMP-responsive element-binding protein-like 2 OS=Bos taurus OX=9913 GN=CREBL2 PE=1 SV=1,GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0016604; GO:0030154; GO:0033138; GO:0045600; GO:0045893; GO:0046326; GO:0046889; GO:0050821,cell differentiation [GO:0030154]; positive regulation of D-glucose import [GO:0046326]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355],nuclear body [GO:0016604]; nucleus [GO:0005634],DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; transcription regulator activity
OG_02465,0.1926354316379635,FUN_009656-T1,Peve_00003553,Pocillopora_meandrina_HIv1___RNAseq.g24581.t1,three_way,62.471,FUN_009656-T1,P31946,1433B_HUMAN,,"14-3-3 protein beta/alpha (Protein 1054) (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein beta/alpha, N-terminally processed]",Homo sapiens (Human),64.4,250.0,2.1e-74,280.4,sp|P31946|1433B_HUMAN 14-3-3 protein beta/alpha OS=Homo sapiens OX=9606 GN=YWHAB PE=1 SV=3,GO:0004860; GO:0004864; GO:0005634; GO:0005737; GO:0005774; GO:0005829; GO:0005925; GO:0006605; GO:0007165; GO:0008104; GO:0016020; GO:0017053; GO:0019899; GO:0019904; GO:0042308; GO:0042470; GO:0042802; GO:0042826; GO:0044877; GO:0045296; GO:0045744; GO:0045892; GO:0045944; GO:0048471; GO:0050815; GO:0051219; GO:0070062; GO:0140311,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of protein import into nucleus [GO:0042308]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; protein targeting [GO:0006605]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription repressor complex [GO:0017053]; vacuolar membrane [GO:0005774],cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein phosphatase inhibitor activity [GO:0004864]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877],GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0043226; GO:0098772; GO:0140313,nucleus; cytosol; regulation of DNA-templated transcription; cytoplasmic vesicle; organelle; molecular function regulator activity; molecular sequestering activity
OG_02490,0.1193306509368358,FUN_009822-T1,Peve_00042911,Pocillopora_meandrina_HIv1___RNAseq.g24544.t1,three_way,83.21233333333333,FUN_009822-T1,O77460,,,,,68.7,211.0,6.9e-87,321.6,sp|O77460|IPYR_DROME Inorganic pyrophosphatase OS=Drosophila melanogaster OX=7227 GN=Nurf-38 PE=1 SV=3,,,,,,
OG_02531,0.4779255250526334,FUN_010606-T1,Peve_00032719,Pocillopora_meandrina_HIv1___RNAseq.g21491.t1,three_way,76.36316666666666,FUN_010606-T1,Q5SSZ7,ZNRF3_MOUSE,,E3 ubiquitin-protein ligase ZNRF3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZNRF3) (Zinc/RING finger protein 3),Mus musculus (Mouse),50.3,302.0,2.7e-80,300.8,sp|Q5SSZ7|ZNRF3_MOUSE E3 ubiquitin-protein ligase ZNRF3 OS=Mus musculus OX=10090 GN=Znrf3 PE=1 SV=1,GO:0004842; GO:0005109; GO:0005886; GO:0006511; GO:0008270; GO:0016055; GO:0016567; GO:0030178; GO:0038018; GO:0060173; GO:0060828; GO:0072089; GO:0090090; GO:2000051; GO:2000095,"limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055]",plasma membrane [GO:0005886],frizzled binding [GO:0005109]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; plasma membrane; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_02532,0.4224594050530088,FUN_010610-T1,Peve_00002553,Pocillopora_meandrina_HIv1___RNAseq.g9919.t1,three_way,68.22433333333333,,,,,,,,,,,,,,,,,
OG_02602,0.6263594062066123,FUN_010728-T1,Peve_00038973,Pocillopora_meandrina_HIv1___RNAseq.g20945.t1,three_way,73.28566666666667,FUN_010728-T1,Q503V9,,,,,57.0,186.0,2.6e-54,213.4,sp|Q503V9|ENDUB_DANRE Uridylate-specific endoribonuclease B OS=Danio rerio OX=7955 GN=endoub PE=2 SV=1,,,,,,
OG_02692,0.4399373533252801,FUN_010955-T1,Peve_00015012,Pocillopora_meandrina_HIv1___RNAseq.g21823.t1,three_way,51.78366666666667,,,,,,,,,,,,,,,,,
OG_02702,0.3559986059813486,FUN_010977-T1,Peve_00013380,Pocillopora_meandrina_HIv1___RNAseq.g22016.t2,three_way,61.6055,FUN_010977-T1,Q8VCM2,NOXO1_MOUSE,,NADPH oxidase organizer 1 (Nox organizer 1) (Sorting nexin-28),Mus musculus (Mouse),34.5,110.0,2e-12,76.3,sp|Q8VCM2|NOXO1_MOUSE NADPH oxidase organizer 1 OS=Mus musculus OX=10090 GN=Noxo1 PE=1 SV=2,GO:0005886; GO:0006801; GO:0016176; GO:0019899; GO:0022617; GO:0035091; GO:0043020,extracellular matrix disassembly [GO:0022617]; superoxide metabolic process [GO:0006801],NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; superoxide-generating NADPH oxidase activator activity [GO:0016176],GO:0005886; GO:0008289; GO:0030198; GO:0098772,plasma membrane; lipid binding; extracellular matrix organization; molecular function regulator activity
OG_02916,0.1033666665208942,FUN_011998-T1,Peve_00000538,Pocillopora_meandrina_HIv1___RNAseq.g24022.t1,three_way,87.02483333333333,FUN_011998-T1,A5PK71,PACRG_BOVIN,,Parkin coregulated gene protein,Bos taurus (Bovine),82.6,201.0,4.8e-99,362.1,sp|A5PK71|PACRG_BOVIN Parkin coregulated gene protein OS=Bos taurus OX=9913 GN=PACRG PE=1 SV=1,GO:0001664; GO:0002177; GO:0003779; GO:0005829; GO:0005879; GO:0007286; GO:0008104; GO:0030317; GO:0030544; GO:0031625; GO:0031982; GO:0043005; GO:0043014; GO:0044297; GO:0048487; GO:0051879; GO:0097225; GO:0097386; GO:0160112,flagellated sperm motility [GO:0030317]; protein localization [GO:0008104]; spermatid development [GO:0007286],axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; cell body [GO:0044297]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; manchette [GO:0002177]; neuron projection [GO:0043005]; sperm midpiece [GO:0097225]; vesicle [GO:0031982],actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625],GO:0005829; GO:0007018; GO:0008092; GO:0022414; GO:0043226; GO:0048856; GO:0048870,cytosol; microtubule-based movement; cytoskeletal protein binding; reproductive process; organelle; anatomical structure development; cell motility
OG_02936,0.3022094296421337,FUN_012041-T2,Peve_00016078,Pocillopora_meandrina_HIv1___RNAseq.g24062.t1,three_way,80.87033333333333,FUN_012041-T2,Q5TCS8,KAD9_HUMAN,,Adenylate kinase 9 (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2),Homo sapiens (Human),43.5,1918.0,0.0,1171.4,sp|Q5TCS8|KAD9_HUMAN Adenylate kinase 9 OS=Homo sapiens OX=9606 GN=AK9 PE=1 SV=2,GO:0004017; GO:0004127; GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006225; GO:0015630; GO:0016887; GO:0031514; GO:0031965; GO:0033862; GO:0036430; GO:0036431; GO:0046705; GO:0047506; GO:0050145,CDP biosynthetic process [GO:0046705]; UDP biosynthetic process [GO:0006225],cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],(d)CMP kinase activity [GO:0004127]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; CMP kinase activity [GO:0036430]; dCMP kinase activity [GO:0036431]; deoxyadenylate kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005929; GO:0016740; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; cilium; transferase activity; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02944,0.4452083869667243,FUN_012058-T1,Peve_00004101,Pocillopora_meandrina_HIv1___RNAseq.g23641.t1,three_way,54.401,FUN_012058-T1,Q7Z020,,,,,28.9,662.0,1.1999999999999999e-46,190.3,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_03079,0.4193967204305592,FUN_012351-T1,Peve_00042524,Pocillopora_meandrina_HIv1___RNAseq.g23280.t1,three_way,33.19883333333333,,,,,,,,,,,,,,,,,
OG_03080,0.6789290346504133,FUN_012352-T1,Peve_00042523,Pocillopora_meandrina_HIv1___RNAseq.g23279.t1,three_way,78.2095,FUN_012352-T1,Q2KIT4,,,,,47.1,365.0,5.2e-84,312.8,sp|Q2KIT4|DNJB4_BOVIN DnaJ homolog subfamily B member 4 OS=Bos taurus OX=9913 GN=DNAJB4 PE=2 SV=1,,,,,,
OG_03093,0.319549615753796,FUN_012378-T1,Peve_00042531,Pocillopora_meandrina_HIv1___RNAseq.g23353.t1,three_way,64.31700000000001,FUN_012378-T1,Q9JKK0,,,,,34.0,194.0,7.4e-20,99.0,sp|Q9JKK0|RCAN3_MOUSE Calcipressin-3 OS=Mus musculus OX=10090 GN=Rcan3 PE=2 SV=1,,,,,,
OG_03116,0.36859294172101,FUN_012430-T1,Peve_00026925,Pocillopora_meandrina_HIv1___RNAseq.g23681.t1,three_way,55.942,FUN_012430-T1,Q7TXL8,,,,,25.4,2226.0,7.9e-140,501.5,sp|Q7TXL8|PPSC_MYCBO Phenolphthiocerol/phthiocerol polyketide synthase subunit C OS=Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) OX=233413 GN=ppsC PE=1 SV=1,,,,,,
OG_03122,0.5447590223357959,FUN_012476-T1,Peve_00004005,Pocillopora_meandrina_HIv1___RNAseq.g23990.t1,three_way,74.48633333333333,FUN_012476-T1,O15247,CLIC2_HUMAN,,Chloride intracellular channel protein 2 (Glutaredoxin-like oxidoreductase CLIC2) (EC 1.8.-.-) (Glutaredoxin-like peroxidase CLIC2) (EC 1.11.1.-) (XAP121),Homo sapiens (Human),31.7,230.0,1.5e-23,111.3,sp|O15247|CLIC2_HUMAN Chloride intracellular channel protein 2 OS=Homo sapiens OX=9606 GN=CLIC2 PE=1 SV=3,GO:0004602; GO:0005254; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006821; GO:0007165; GO:0010880; GO:0010881; GO:0016020; GO:0034707,chloride transport [GO:0006821]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; signal transduction [GO:0007165],chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chloride channel activity [GO:0005254]; glutathione peroxidase activity [GO:0004602],GO:0003824; GO:0005215; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0016209; GO:0016491; GO:0043226,catalytic activity; transporter activity; nucleus; nucleoplasm; cytosol; plasma membrane; antioxidant activity; oxidoreductase activity; organelle
OG_03125,0.321834498227191,FUN_012481-T1,Peve_00003997,Pocillopora_meandrina_HIv1___TS.g16861.t1,three_way,79.94766666666666,,,,,,,,,,,,,,,,,
OG_03138,0.237358840875685,FUN_012520-T1,Peve_00014742,Pocillopora_meandrina_HIv1___RNAseq.g23959.t1,three_way,84.107,FUN_012520-T1,A8E4N3,RSPH3_BOVIN,,Radial spoke head protein 3 homolog (A-kinase anchor protein RSPH3) (Radial spoke head-like protein 2),Bos taurus (Bovine),64.0,331.0,1.3e-102,374.8,sp|A8E4N3|RSPH3_BOVIN Radial spoke head protein 3 homolog OS=Bos taurus OX=9913 GN=RSPH3 PE=2 SV=1,GO:0001535; GO:0005929; GO:0097729,,9+2 motile cilium [GO:0097729]; cilium [GO:0005929]; radial spoke head [GO:0001535],,GO:0005929; GO:0043226,cilium; organelle
OG_03187,0.3204494807752561,FUN_012657-T1,Peve_00022119,Pocillopora_meandrina_HIv1___RNAseq.g22895.t1,three_way,70.13616666666667,FUN_012657-T1,Q9UK58,,,,,56.1,173.0,6.700000000000001e-48,193.0,sp|Q9UK58|CCNL1_HUMAN Cyclin-L1 OS=Homo sapiens OX=9606 GN=CCNL1 PE=1 SV=1,,,,,,
OG_03215,0.1167466661555806,FUN_012733-T1,Peve_00013152,Pocillopora_meandrina_HIv1___RNAseq.8836_t,three_way,69.916,FUN_012733-T1,Q9ESQ4,NMUR2_RAT,,Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor TGR-1) (G-protein-coupled receptor FM-4),Rattus norvegicus (Rat),23.5,328.0,2.7e-08,61.2,sp|Q9ESQ4|NMUR2_RAT Neuromedin-U receptor 2 OS=Rattus norvegicus OX=10116 GN=Nmur2 PE=1 SV=2,GO:0001607; GO:0002023; GO:0005229; GO:0005525; GO:0005886; GO:0007200; GO:0007218; GO:0007625; GO:0008188; GO:0016020; GO:0042924; GO:0048265; GO:0050482; GO:0051930,arachidonate secretion [GO:0050482]; grooming behavior [GO:0007625]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; response to pain [GO:0048265],membrane [GO:0016020]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; intracellularly calcium-gated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188],GO:0005215; GO:0005886; GO:0060089,transporter activity; plasma membrane; molecular transducer activity
OG_03286,0.3214130989027108,FUN_013326-T1,Peve_00022536,Pocillopora_meandrina_HIv1___RNAseq.g13101.t1,three_way,85.618,FUN_013326-T1,A8JF70,ODA1_CHLRE,,Outer dynein arm protein 1 (Docking complex component 2),Chlamydomonas reinhardtii (Chlamydomonas smithii),32.0,500.0,5.699999999999999e-53,210.3,sp|A8JF70|ODA1_CHLRE Outer dynein arm protein 1 OS=Chlamydomonas reinhardtii OX=3055 GN=ODA1 PE=1 SV=1,GO:0036157; GO:0036158; GO:0060294,cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158],outer dynein arm [GO:0036157],,GO:0007018; GO:0065003,microtubule-based movement; protein-containing complex assembly
OG_03309,0.7177022303920516,FUN_013385-T1,Peve_00015992,Pocillopora_meandrina_HIv1___RNAseq.g22980.t2,three_way,65.83083333333333,FUN_013385-T1,Q24180,DEAF1_DROME,,Deformed epidermal autoregulatory factor 1 (Protein DEAF-1),Drosophila melanogaster (Fruit fly),45.2,84.0,2.6e-16,87.8,sp|Q24180|DEAF1_DROME Deformed epidermal autoregulatory factor 1 OS=Drosophila melanogaster OX=7227 GN=Deaf1 PE=1 SV=1,GO:0000981; GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0008270; GO:0009792; GO:0043565; GO:0045893; GO:0050776,embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]; polytene chromosome [GO:0005700],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005694; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; chromosome; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_03318,0.1424572725213608,FUN_013396-T1,Peve_00028088,Pocillopora_meandrina_HIv1___TS.g15820.t1,three_way,43.746,,,,,,,,,,,,,,,,,
OG_03335,0.5484847919865149,FUN_013556-T1,Peve_00038569,Pocillopora_meandrina_HIv1___RNAseq.g22960.t1,three_way,59.44166666666667,FUN_013556-T1,Q6NR09,EGRAP_DROME,,EGFR adapter protein,Drosophila melanogaster (Fruit fly),34.3,137.0,7.7e-13,77.0,sp|Q6NR09|EGRAP_DROME EGFR adapter protein OS=Drosophila melanogaster OX=7227 GN=Egfrap PE=1 SV=1,GO:0005925; GO:0030971; GO:0042059; GO:0045179,negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059],apical cortex [GO:0045179]; focal adhesion [GO:0005925],receptor tyrosine kinase binding [GO:0030971],,
OG_03338,0.1722611612229443,FUN_013562-T1,Peve_00018191,Pocillopora_meandrina_HIv1___RNAseq.g22973.t1,three_way,41.28366666666666,,,,,,,,,,,,,,,,,
OG_03353,0.289488913975006,FUN_013589-T1,Peve_00018180,Pocillopora_meandrina_HIv1___RNAseq.g13493.t1,three_way,79.63766666666666,FUN_013589-T1,Q4KKZ1,,,,,39.8,181.0,3.5000000000000004e-28,126.7,sp|Q4KKZ1|CF107_MOUSE Cilia- and flagella-associated protein 107 OS=Mus musculus OX=10090 GN=Cfap107 PE=1 SV=2,,,,,,
OG_03365,0.2544236294386281,FUN_013608-T1,Peve_00002652,Pocillopora_meandrina_HIv1___RNAseq.g13524.t1,three_way,66.57066666666667,,,,,,,,,,,,,,,,,
OG_03680,0.520278530408337,FUN_014939-T1,Peve_00037138,Pocillopora_meandrina_HIv1___RNAseq.g21096.t2,three_way,83.04633333333334,FUN_014939-T1,Q2KJ16,PHKG2_BOVIN,,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (Phosphorylase kinase subunit gamma-2)",Bos taurus (Bovine),53.3,360.0,1.2e-111,404.8,"sp|Q2KJ16|PHKG2_BOVIN Phosphorylase b kinase gamma catalytic chain, liver/testis isoform OS=Bos taurus OX=9913 GN=PHKG2 PE=2 SV=1",GO:0004689; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005964; GO:0005977; GO:0005980; GO:0007165; GO:0045819,glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; positive regulation of glycogen catabolic process [GO:0045819]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964],ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; phosphorylase kinase activity [GO:0004689],GO:0003824; GO:0005829; GO:0005975; GO:0006091; GO:0016740; GO:0140096,"catalytic activity; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; catalytic activity, acting on a protein"
OG_03696,0.2559951565002185,FUN_014965-T1,Peve_00006259,Pocillopora_meandrina_HIv1___RNAseq.g21129.t1,three_way,85.602,FUN_014965-T1,Q8TBY9,,,,,45.2,938.0,2.5999999999999998e-244,846.7,sp|Q8TBY9|CF251_HUMAN Cilia- and flagella-associated protein 251 OS=Homo sapiens OX=9606 GN=CFAP251 PE=1 SV=2,,,,,,
OG_03743,0.6627953423198283,FUN_015050-T1,Peve_00001172,Pocillopora_meandrina_HIv1___RNAseq.g21265.t1,three_way,70.01583333333333,FUN_015050-T1,Q8CHW5,,,,,38.3,120.0,7.4e-10,67.4,sp|Q8CHW5|BICL2_MOUSE BICD family-like cargo adapter 2 OS=Mus musculus OX=10090 GN=Bicdl2 PE=1 SV=1,,,,,,
OG_03759,0.2577474559544703,FUN_015068-T1,Peve_00022389,Pocillopora_meandrina_HIv1___RNAseq.g21285.t1,three_way,87.73183333333334,FUN_015068-T1,Q969V4,TEKT1_HUMAN,,Tektin-1,Homo sapiens (Human),52.9,397.0,1.9e-111,404.1,sp|Q969V4|TEKT1_HUMAN Tektin-1 OS=Homo sapiens OX=9606 GN=TEKT1 PE=1 SV=1,GO:0005634; GO:0005879; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0160111,cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm flagellum [GO:0036126],,GO:0005634; GO:0005856; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0048870,nucleus; cytoskeleton; cilium; microtubule-based movement; reproductive process; organelle; cilium organization; cell motility
OG_03814,0.2140054907398107,FUN_015225-T1,Peve_00013662,Pocillopora_meandrina_HIv1___RNAseq.g22184.t1,three_way,77.971,FUN_015225-T1,Q6IRI9,FMO2_RAT,,Dimethylaniline monooxygenase [N-oxide-forming] 2 (EC 1.14.13.-) (Dimethylaniline oxidase 2) (Pulmonary flavin-containing monooxygenase 2) (FMO 2),Rattus norvegicus (Rat),47.2,525.0,3.3e-138,493.4,sp|Q6IRI9|FMO2_RAT Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Rattus norvegicus OX=10116 GN=Fmo2 PE=2 SV=3,GO:0004497; GO:0004499; GO:0005789; GO:0006082; GO:0006739; GO:0006805; GO:0009404; GO:0016020; GO:0046322; GO:0050660; GO:0050661; GO:0072592; GO:0097009,energy homeostasis [GO:0097009]; NADP metabolic process [GO:0006739]; negative regulation of fatty acid oxidation [GO:0046322]; organic acid metabolic process [GO:0006082]; oxygen metabolic process [GO:0072592]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],"flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",GO:0003824; GO:0016491; GO:0055086,catalytic activity; oxidoreductase activity; nucleobase-containing small molecule metabolic process
OG_03875,0.1019766015682432,FUN_015406-T1,Peve_00000203,Pocillopora_meandrina_HIv1___RNAseq.g21679.t1,three_way,55.48783333333333,,,,,,,,,,,,,,,,,
OG_03958,0.2767242862764939,FUN_016103-T1,Peve_00010768,Pocillopora_meandrina_HIv1___RNAseq.g21593.t1,three_way,67.107,FUN_016103-T1,O95721,SNP29_HUMAN,,Synaptosomal-associated protein 29 (SNAP-29) (Soluble 29 kDa NSF attachment protein) (Vesicle-membrane fusion protein SNAP-29),Homo sapiens (Human),30.6,255.0,2.2e-21,104.4,sp|O95721|SNP29_HUMAN Synaptosomal-associated protein 29 OS=Homo sapiens OX=9606 GN=SNAP29 PE=1 SV=1,GO:0000139; GO:0000421; GO:0005484; GO:0005737; GO:0005739; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0006887; GO:0006903; GO:0015031; GO:0016082; GO:0016240; GO:0019905; GO:0020018; GO:0031201; GO:0031629; GO:0035577; GO:0060271; GO:0061025; GO:0097352; GO:0098793,autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; membrane fusion [GO:0061025]; protein transport [GO:0015031]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle targeting [GO:0006903],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; azurophil granule membrane [GO:0035577]; centrosome [GO:0005813]; ciliary pocket membrane [GO:0020018]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201],SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905],GO:0005739; GO:0005773; GO:0005815; GO:0005829; GO:0005886; GO:0016192; GO:0043226; GO:0044782; GO:0060090; GO:0061024; GO:0065003,mitochondrion; vacuole; microtubule organizing center; cytosol; plasma membrane; vesicle-mediated transport; organelle; cilium organization; molecular adaptor activity; membrane organization; protein-containing complex assembly
OG_04005,0.2475592191923607,FUN_016304-T1,Peve_00032294,Pocillopora_meandrina_HIv1___RNAseq.g10041.t1,three_way,94.68466666666669,FUN_016304-T1,O42406,,,,,86.9,191.0,7.2e-98,358.2,sp|O42406|SIX3_CHICK Homeobox protein SIX3 OS=Gallus gallus OX=9031 GN=SIX3 PE=1 SV=2,,,,,,
OG_04022,0.2147245649127437,FUN_016327-T1,Peve_00032378,Pocillopora_meandrina_HIv1___RNAseq.g9682.t1,three_way,50.593,,,,,,,,,,,,,,,,,
OG_04046,0.3911730417335535,FUN_016360-T1,Peve_00004338,Pocillopora_meandrina_HIv1___RNAseq.g9672.t1,three_way,64.9715,FUN_016360-T1,Q9Y6R0,NUMBL_HUMAN,,Numb-like protein (Numb-related protein) (Numb-R),Homo sapiens (Human),58.1,160.0,1e-46,189.5,sp|Q9Y6R0|NUMBL_HUMAN Numb-like protein OS=Homo sapiens OX=9606 GN=NUMBL PE=1 SV=1,GO:0005737; GO:0007399; GO:0007409; GO:0019221; GO:0019538; GO:0021670; GO:0021849; GO:0034332; GO:0050769; GO:0050775; GO:0098978; GO:0150052,adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; cytokine-mediated signaling pathway [GO:0019221]; lateral ventricle development [GO:0021670]; nervous system development [GO:0007399]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neurogenesis [GO:0050769]; protein metabolic process [GO:0019538]; regulation of postsynapse assembly [GO:0150052],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978],,GO:0034330; GO:0048856,cell junction organization; anatomical structure development
OG_04082,0.1321290788732915,FUN_016418-T1,Peve_00023003,Pocillopora_meandrina_HIv1___RNAseq.g9800.t1,three_way,48.49066666666666,,,,,,,,,,,,,,,,,
OG_04083,0.386785391383161,FUN_016419-T1,Peve_00023004,Pocillopora_meandrina_HIv1___RNAseq.g9801.t1,three_way,61.829,,,,,,,,,,,,,,,,,
OG_04155,0.1643046874565783,FUN_016622-T1,Peve_00011211,Pocillopora_meandrina_HIv1___RNAseq.g9609.t1,three_way,83.40233333333333,FUN_016622-T1,P36975,,,,,51.5,202.0,4.2e-49,196.1,sp|P36975|SNP25_DROME Synaptosomal-associated protein 25 OS=Drosophila melanogaster OX=7227 GN=Snap25 PE=2 SV=1,,,,,,
OG_04193,0.4089496293108186,FUN_016717-T1,Peve_00014667,Pocillopora_meandrina_HIv1___RNAseq.g226.t1,three_way,70.61533333333334,,,,,,,,,,,,,,,,,
OG_04219,0.3363334996924261,FUN_016970-T1,Peve_00025293,Pocillopora_meandrina_HIv1___RNAseq.g9903.t2,three_way,56.20816666666666,,,,,,,,,,,,,,,,,
OG_04278,0.3265625517141723,FUN_017839-T1,Peve_00011466,Pocillopora_meandrina_HIv1___RNAseq.g9632.t1,three_way,66.87983333333334,FUN_017839-T1,Q9BYW2,,,,,31.0,1246.0,5.6e-130,467.2,sp|Q9BYW2|SETD2_HUMAN Histone-lysine N-methyltransferase SETD2 OS=Homo sapiens OX=9606 GN=SETD2 PE=1 SV=3,,,,,,
OG_04304,0.6340264199667848,FUN_017889-T1,Peve_00001917,Pocillopora_meandrina_HIv1___RNAseq.g9667.t1,three_way,53.98566666666667,FUN_017889-T1,Q90X67,,,,,33.7,184.0,1.3e-19,97.8,sp|Q90X67|SOCS3_CHICK Suppressor of cytokine signaling 3 OS=Gallus gallus OX=9031 GN=SOCS3 PE=2 SV=1,,,,,,
OG_04463,0.3013272292514405,FUN_019342-T1,Peve_00032901,Pocillopora_meandrina_HIv1___RNAseq.g20862.t1,three_way,54.33,FUN_019342-T1,Q01071,ESMD_DROME,,Enhancer of split mdelta protein (E(spl)mdelta) (HLH-mdelta) (Split locus enhancer protein mC),Drosophila melanogaster (Fruit fly),36.6,123.0,2e-12,74.3,sp|Q01071|ESMD_DROME Enhancer of split mdelta protein OS=Drosophila melanogaster OX=7227 GN=E(spl)mdelta-HLH PE=1 SV=1,GO:0000122; GO:0000978; GO:0005634; GO:0007219; GO:0007525; GO:0043565; GO:0045466; GO:0046983; GO:0048052; GO:0050767; GO:1902692; GO:1990837,negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; R1/R6 cell differentiation [GO:0048052]; R7 cell differentiation [GO:0045466]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; somatic muscle development [GO:0007525],nucleus [GO:0005634],protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development
OG_04480,0.258637798428451,FUN_021451-T1,Peve_00016702,Pocillopora_meandrina_HIv1___RNAseq.g2924.t1,three_way,77.19016666666667,FUN_021451-T1,Q8R0S1,ATF7_MOUSE,,Cyclic AMP-dependent transcription factor ATF-7 (cAMP-dependent transcription factor ATF-7) (Activating transcription factor 7) (Transcription factor ATF-A),Mus musculus (Mouse),36.8,419.0,9.7e-51,202.6,sp|Q8R0S1|ATF7_MOUSE Cyclic AMP-dependent transcription factor ATF-7 OS=Mus musculus OX=10090 GN=Atf7 PE=1 SV=1,GO:0000781; GO:0001701; GO:0001889; GO:0002244; GO:0003677; GO:0003700; GO:0005654; GO:0007507; GO:0008270; GO:0038066; GO:0097284,heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; hepatocyte apoptotic process [GO:0097284]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; p38MAPK cascade [GO:0038066],"chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]",DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270],GO:0003677; GO:0005654; GO:0012501; GO:0030154; GO:0048856; GO:0140110,DNA binding; nucleoplasm; programmed cell death; cell differentiation; anatomical structure development; transcription regulator activity
OG_04495,0.282333473205779,FUN_021927-T1,Peve_00000369,Pocillopora_meandrina_HIv1___RNAseq.g2914.t1,three_way,67.16066666666667,,,,,,,,,,,,,,,,,
OG_04499,0.3558691648829816,FUN_021937-T1,Peve_00023931,Pocillopora_meandrina_HIv1___RNAseq.g2961.t1,three_way,82.98416666666667,FUN_021937-T1,P50549,ETV1_HUMAN,,ETS translocation variant 1 (Ets-related protein 81),Homo sapiens (Human),35.8,477.0,1.3e-58,228.8,sp|P50549|ETV1_HUMAN ETS translocation variant 1 OS=Homo sapiens OX=9606 GN=ETV1 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0007411; GO:0007517; GO:0007638; GO:0030154; GO:0045944; GO:0048935; GO:1990837,axon guidance [GO:0007411]; cell differentiation [GO:0030154]; mechanosensory behavior [GO:0007638]; muscle organ development [GO:0007517]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04516,0.4701947073259227,FUN_022049-T1,Peve_00032394,Pocillopora_meandrina_HIv1___RNAseq.g4599.t1,three_way,67.69266666666667,FUN_022049-T1,Q9C098,DCLK3_HUMAN,,Serine/threonine-protein kinase DCLK3 (EC 2.7.11.1) (Doublecortin domain-containing protein 3C) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3),Homo sapiens (Human),59.1,269.0,2e-91,338.6,sp|Q9C098|DCLK3_HUMAN Serine/threonine-protein kinase DCLK3 OS=Homo sapiens OX=9606 GN=DCLK3 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0034504; GO:0106310,protein localization to nucleus [GO:0034504],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04566,0.4465578352771737,FUN_022209-T1,Peve_00008601,Pocillopora_meandrina_HIv1___RNAseq.g4801.t1,three_way,46.54666666666667,FUN_022209-T1,Q7KM13,,,,,52.7,91.0,2.1e-14,81.3,sp|Q7KM13|HEY_DROME Hairy/enhancer-of-split related with YRPW motif protein OS=Drosophila melanogaster OX=7227 GN=Hey PE=2 SV=1,,,,,,
OG_04588,0.1254184997965962,FUN_022260-T1,Peve_00043990,Pocillopora_meandrina_HIv1___RNAseq.g4718.t1,three_way,93.872,FUN_022260-T1,P61209,,,,,95.0,179.0,3.3e-95,349.0,sp|P61209|ARF1_DROME ADP-ribosylation factor 1 OS=Drosophila melanogaster OX=7227 GN=Arf1 PE=1 SV=2,,,,,,
OG_04666,0.2150052244312675,FUN_022414-T1,Peve_00037631,Pocillopora_meandrina_HIv1___RNAseq.g4357.t1,three_way,37.86366666666667,,,,,,,,,,,,,,,,,
OG_04693,0.6567543511305454,FUN_022485-T1,Peve_00002925,Pocillopora_meandrina_HIv1___RNAseq.g4293.t1,three_way,88.12733333333333,,,,,,,,,,,,,,,,,
OG_04733,0.2824391528443827,FUN_022602-T1,Peve_00012234,Pocillopora_meandrina_HIv1___RNAseq.g4421.t1,three_way,70.62083333333334,FUN_022602-T1,Q91VY9,,,,,38.8,477.0,4.4e-81,303.1,sp|Q91VY9|ZN622_MOUSE Cytoplasmic 60S subunit biogenesis factor ZNF622 OS=Mus musculus OX=10090 GN=Znf622 PE=1 SV=1,,,,,,
OG_04765,0.4486503426100797,FUN_022665-T1,Peve_00036260,Pocillopora_meandrina_HIv1___RNAseq.g3193.t1,three_way,60.42666666666667,,,,,,,,,,,,,,,,,
OG_04789,0.2449948881685731,FUN_022703-T1,Peve_00018677,Pocillopora_meandrina_HIv1___RNAseq.g4823.t1,three_way,91.9455,FUN_022703-T1,P11233,RALA_HUMAN,,Ras-related protein Ral-A (EC 3.6.5.2),Homo sapiens (Human),81.1,185.0,4.5e-77,288.9,sp|P11233|RALA_HUMAN Ras-related protein Ral-A OS=Homo sapiens OX=9606 GN=RALA PE=1 SV=1,GO:0001843; GO:0003924; GO:0003925; GO:0005525; GO:0005739; GO:0005886; GO:0005925; GO:0006887; GO:0006935; GO:0007165; GO:0007265; GO:0009986; GO:0017022; GO:0017157; GO:0019003; GO:0030659; GO:0031623; GO:0031625; GO:0031755; GO:0032154; GO:0032956; GO:0045742; GO:0051117; GO:0051301; GO:0051491; GO:0051665; GO:0070062; GO:0072655; GO:0090141; GO:0090543; GO:0097060; GO:0098685; GO:0099149,cell division [GO:0051301]; chemotaxis [GO:0006935]; establishment of protein localization to mitochondrion [GO:0072655]; exocytosis [GO:0006887]; membrane raft localization [GO:0051665]; neural tube closure [GO:0001843]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of mitochondrial fission [GO:0090141]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of exocytosis [GO:0017157]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; signal transduction [GO:0007165],cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060],ATPase binding [GO:0051117]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0003924; GO:0005739; GO:0005886; GO:0008092; GO:0016192; GO:0016787; GO:0043226; GO:0098772,catalytic activity; GTPase activity; mitochondrion; plasma membrane; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; organelle; molecular function regulator activity
OG_04830,0.2651770880640621,FUN_022824-T1,Peve_00030469,Pocillopora_meandrina_HIv1___RNAseq.g3440.t1,three_way,97.61033333333332,FUN_022824-T1,B2RW38,CFA58_MOUSE,,Cilia- and flagella-associated protein 58,Mus musculus (Mouse),69.4,788.0,3.3999999999999996e-177,623.6,sp|B2RW38|CFA58_MOUSE Cilia- and flagella-associated protein 58 OS=Mus musculus OX=10090 GN=Cfap58 PE=1 SV=1,GO:0005737; GO:0005813; GO:0007219; GO:0007288; GO:0030317; GO:0036126; GO:0060271; GO:0097225; GO:0120229; GO:0120316; GO:0120317,cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; Notch signaling pathway [GO:0007219]; protein localization to motile cilium [GO:0120229]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; sperm mitochondrial sheath assembly [GO:0120317],centrosome [GO:0005813]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225],,GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0048870,microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; cilium organization; cell motility
OG_05043,0.3998931095919685,FUN_023227-T1,Peve_00029804,Pocillopora_meandrina_HIv1___RNAseq.g717.t1,three_way,76.54016666666666,FUN_023227-T1,Q8NB25,F184A_HUMAN,,Protein FAM184A,Homo sapiens (Human),26.8,1100.0,2.1e-22,109.8,sp|Q8NB25|F184A_HUMAN Protein FAM184A OS=Homo sapiens OX=9606 GN=FAM184A PE=1 SV=3,GO:0000932; GO:0005615; GO:0005829; GO:0034451; GO:0036064; GO:0043231,,centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; P-body [GO:0000932],,GO:0005615; GO:0005815; GO:0005829; GO:0043226,extracellular space; microtubule organizing center; cytosol; organelle
OG_05199,0.3713482302862977,FUN_023579-T1,Peve_00035155,Pocillopora_meandrina_HIv1___RNAseq.g3533.t1,three_way,74.84533333333333,FUN_023579-T1,Q9BST9,RTKN_HUMAN,,Rhotekin,Homo sapiens (Human),30.6,438.0,3.7000000000000004e-48,194.1,sp|Q9BST9|RTKN_HUMAN Rhotekin OS=Homo sapiens OX=9606 GN=RTKN PE=1 SV=2,GO:0000281; GO:0000915; GO:0005095; GO:0005525; GO:0005826; GO:0005829; GO:0006915; GO:0007165; GO:0007266; GO:0031106; GO:0031267; GO:0042981,actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; mitotic cytokinesis [GO:0000281]; regulation of apoptotic process [GO:0042981]; Rho protein signal transduction [GO:0007266]; septin ring organization [GO:0031106]; signal transduction [GO:0007165],actomyosin contractile ring [GO:0005826]; cytosol [GO:0005829],GTP binding [GO:0005525]; GTPase inhibitor activity [GO:0005095]; small GTPase binding [GO:0031267],GO:0000910; GO:0005829; GO:0007010; GO:0012501; GO:0098772,cytokinesis; cytosol; cytoskeleton organization; programmed cell death; molecular function regulator activity
OG_05223,0.3053347933703793,FUN_023635-T1,Peve_00027832,Pocillopora_meandrina_HIv1___RNAseq.g17812.t1,three_way,82.328,FUN_023635-T1,A0A1L8GXY4,,,,,37.3,1717.0,8.1e-300,1031.9,sp|A0A1L8GXY4|CFA43_XENLA Cilia- and flagella-associated protein 43 OS=Xenopus laevis OX=8355 GN=cfap43 PE=2 SV=1,,,,,,
OG_05253,0.4713873111127006,FUN_023701-T1,Peve_00017415,Pocillopora_meandrina_HIv1___RNAseq.g17594.t1,three_way,79.94866666666667,FUN_023701-T1,Q8IYX7,SAXO1_HUMAN,,Stabilizer of axonemal microtubules 1,Homo sapiens (Human),21.5,498.0,2.4e-12,75.1,sp|Q8IYX7|SAXO1_HUMAN Stabilizer of axonemal microtubules 1 OS=Homo sapiens OX=9606 GN=SAXO1 PE=1 SV=2,GO:0005813; GO:0005814; GO:0005856; GO:0005879; GO:0008017; GO:0009631; GO:0030030; GO:0031514; GO:0036064; GO:0036126; GO:0045724; GO:0050821; GO:0070417,cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821],axonemal microtubule [GO:0005879]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126],microtubule binding [GO:0008017],GO:0005815; GO:0005856; GO:0005929; GO:0008092; GO:0043226,microtubule organizing center; cytoskeleton; cilium; cytoskeletal protein binding; organelle
OG_05323,0.557158377679326,FUN_024015-T1,Peve_00040419,Pocillopora_meandrina_HIv1___RNAseq.g19286.t1,three_way,70.89716666666666,FUN_024015-T1,Q6ZR37,PKHG7_HUMAN,,Pleckstrin homology domain-containing family G member 7 (PH domain-containing family G member 7),Homo sapiens (Human),35.4,540.0,1.8e-73,279.3,sp|Q6ZR37|PKHG7_HUMAN Pleckstrin homology domain-containing family G member 7 OS=Homo sapiens OX=9606 GN=PLEKHG7 PE=1 SV=2,GO:0005085; GO:0007266,Rho protein signal transduction [GO:0007266],,guanyl-nucleotide exchange factor activity [GO:0005085],GO:0098772,molecular function regulator activity
OG_05427,0.236751701784568,FUN_024372-T1,Peve_00018876,Pocillopora_meandrina_HIv1___RNAseq.g18588.t1,three_way,75.26633333333334,FUN_024372-T1,Q6ZV65,FA47E_HUMAN,,Protein FAM47E,Homo sapiens (Human),29.6,361.0,8.7e-28,126.3,sp|Q6ZV65|FA47E_HUMAN Protein FAM47E OS=Homo sapiens OX=9606 GN=FAM47E PE=1 SV=3,GO:0000785; GO:0005634; GO:0005737; GO:0008047; GO:0045815; GO:0071168,protein localization to chromatin [GO:0071168]; transcription initiation-coupled chromatin remodeling [GO:0045815],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634],enzyme activator activity [GO:0008047],GO:0005634; GO:0006325; GO:0043226; GO:0098772,nucleus; chromatin organization; organelle; molecular function regulator activity
OG_05440,0.3771501331207879,FUN_024393-T1,Peve_00005016,Pocillopora_meandrina_HIv1___RNAseq.g18624.t1,three_way,66.556,FUN_024393-T1,P42674,,,,,48.3,201.0,1.4e-44,182.2,sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1,,,,,,
OG_05486,0.484714151794675,FUN_024483-T1,Peve_00010585,Pocillopora_meandrina_HIv1___RNAseq.g19068.t1,three_way,49.94483333333333,FUN_024483-T1,Q9UHB7,,,,,27.0,248.0,1.4e-13,80.5,sp|Q9UHB7|AFF4_HUMAN AF4/FMR2 family member 4 OS=Homo sapiens OX=9606 GN=AFF4 PE=1 SV=1,,,,,,
OG_05797,0.0865334150625528,FUN_025780-T1,Peve_00009651,Pocillopora_meandrina_HIv1___RNAseq.g10358.t1,three_way,87.72200000000001,FUN_025780-T1,P18687,,,,,71.6,556.0,2.2e-220,766.5,"sp|P18687|CH60_CRIGR 60 kDa heat shock protein, mitochondrial OS=Cricetulus griseus OX=10029 GN=HSPD1 PE=2 SV=1",,,,,,
OG_05812,0.2189057046929282,FUN_025814-T1,Peve_00002523,Pocillopora_meandrina_HIv1___RNAseq.g9336.t1,three_way,66.91966666666667,FUN_025814-T1,O15520,FGF10_HUMAN,,Fibroblast growth factor 10 (FGF-10) (Keratinocyte growth factor 2),Homo sapiens (Human),32.0,122.0,1.2e-12,74.7,sp|O15520|FGF10_HUMAN Fibroblast growth factor 10 OS=Homo sapiens OX=9606 GN=FGF10 PE=1 SV=1,GO:0000132; GO:0001525; GO:0001656; GO:0001759; GO:0001823; GO:0001935; GO:0001938; GO:0001974; GO:0003338; GO:0005104; GO:0005111; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005886; GO:0007368; GO:0007431; GO:0008083; GO:0008201; GO:0008284; GO:0008543; GO:0008589; GO:0009880; GO:0009986; GO:0010634; GO:0010838; GO:0016055; GO:0021983; GO:0022008; GO:0030036; GO:0030334; GO:0030538; GO:0030857; GO:0030878; GO:0030916; GO:0030949; GO:0031016; GO:0031069; GO:0031076; GO:0032355; GO:0032496; GO:0032781; GO:0032808; GO:0032925; GO:0034394; GO:0035019; GO:0042056; GO:0042060; GO:0042246; GO:0042475; GO:0042693; GO:0043410; GO:0043616; GO:0045739; GO:0045747; GO:0045944; GO:0046579; GO:0046877; GO:0048010; GO:0048144; GO:0048146; GO:0048536; GO:0048538; GO:0048557; GO:0048754; GO:0048807; GO:0048808; GO:0050671; GO:0050673; GO:0050674; GO:0050677; GO:0050679; GO:0050731; GO:0050872; GO:0050918; GO:0050930; GO:0051145; GO:0051549; GO:0060019; GO:0060054; GO:0060174; GO:0060428; GO:0060430; GO:0060436; GO:0060447; GO:0060449; GO:0060496; GO:0060510; GO:0060513; GO:0060595; GO:0060615; GO:0060661; GO:0060664; GO:0060665; GO:0060667; GO:0060879; GO:0060915; GO:0061033; GO:0061115; GO:0070075; GO:0070343; GO:0070352; GO:0070371; GO:0070374; GO:0070384; GO:0071338; GO:0072089; GO:0090263; GO:0097192; GO:1900087; GO:1902178; GO:2000647; GO:2000648; GO:2001240,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching morphogenesis of an epithelial tube [GO:0048754]; bronchiole morphogenesis [GO:0060436]; bud elongation involved in lung branching [GO:0060449]; bud outgrowth involved in lung branching [GO:0060447]; determination of left/right symmetry [GO:0007368]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic genitalia morphogenesis [GO:0030538]; embryonic pattern specification [GO:0009880]; endothelial cell proliferation [GO:0001935]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; female genitalia morphogenesis [GO:0048807]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast proliferation [GO:0048144]; hair follicle morphogenesis [GO:0031069]; Harderian gland development [GO:0070384]; induction of positive chemotaxis [GO:0050930]; keratinocyte proliferation [GO:0043616]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; lung epithelium development [GO:0060428]; lung proximal/distal axis specification [GO:0061115]; lung saccule development [GO:0060430]; male genitalia morphogenesis [GO:0048808]; mammary gland bud formation [GO:0060615]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal-epithelial cell signaling involved in lung development [GO:0060496]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; metanephros morphogenesis [GO:0003338]; muscle cell fate commitment [GO:0042693]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of stem cell proliferation [GO:2000647]; neurogenesis [GO:0022008]; odontogenesis of dentin-containing tooth [GO:0042475]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive chemotaxis [GO:0050918]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA repair [GO:0045739]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hair follicle cell proliferation [GO:0071338]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urothelial cell proliferation [GO:0050677]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of white fat cell proliferation [GO:0070352]; prostatic bud formation [GO:0060513]; protein localization to cell surface [GO:0034394]; radial glial cell differentiation [GO:0060019]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell migration [GO:0030334]; regulation of saliva secretion [GO:0046877]; regulation of smoothened signaling pathway [GO:0008589]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; salivary gland development [GO:0007431]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; semicircular canal fusion [GO:0060879]; smooth muscle cell differentiation [GO:0051145]; somatic stem cell population maintenance [GO:0035019]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; submandibular salivary gland formation [GO:0060661]; tear secretion [GO:0070075]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tissue regeneration [GO:0042246]; type II pneumocyte differentiation [GO:0060510]; urothelial cell proliferation [GO:0050674]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; white fat cell differentiation [GO:0050872]; white fat cell proliferation [GO:0070343]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chemoattractant activity [GO:0042056]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111],GO:0005576; GO:0005615; GO:0005634; GO:0005886; GO:0006355; GO:0007010; GO:0022414; GO:0023052; GO:0030154; GO:0042060; GO:0043226; GO:0048018; GO:0048856; GO:0098772,extracellular region; extracellular space; nucleus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; reproductive process; signaling; cell differentiation; wound healing; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_05883,0.1142118180037081,FUN_026036-T1,Peve_00022187,Pocillopora_meandrina_HIv1___RNAseq.g10549.t1,three_way,71.13533333333334,,,,,,,,,,,,,,,,,
OG_05906,0.2409350121629669,FUN_026093-T1,Peve_00036299,Pocillopora_meandrina_HIv1___RNAseq.g10574.t1a,three_way,64.66183333333333,FUN_026093-T1,Q9Y6M1,IF2B2_HUMAN,,Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (Hepatocellular carcinoma autoantigen p62) (IGF-II mRNA-binding protein 2) (VICKZ family member 2),Homo sapiens (Human),30.0,474.0,8.6e-34,146.4,sp|Q9Y6M1|IF2B2_HUMAN Insulin-like growth factor 2 mRNA-binding protein 2 OS=Homo sapiens OX=9606 GN=IGF2BP2 PE=1 SV=2,GO:0000932; GO:0001817; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007399; GO:0009653; GO:0010494; GO:0017148; GO:0043489; GO:0045182; GO:0048027; GO:0051028; GO:0070934; GO:0097009; GO:0106106; GO:1990247,anatomical structure morphogenesis [GO:0009653]; cold-induced thermogenesis [GO:0106106]; CRD-mediated mRNA stabilization [GO:0070934]; energy homeostasis [GO:0097009]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; regulation of cytokine production [GO:0001817]; RNA stabilization [GO:0043489],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932],mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182],GO:0003723; GO:0005634; GO:0005829; GO:0005856; GO:0043226; GO:0045182; GO:0048856; GO:0060090,RNA binding; nucleus; cytosol; cytoskeleton; organelle; translation regulator activity; anatomical structure development; molecular adaptor activity
OG_06108,0.4902447056806766,FUN_027813-T1,Peve_00036478,Pocillopora_meandrina_HIv1___RNAseq.g13891.t1,three_way,60.12866666666667,,,,,,,,,,,,,,,,,
OG_06132,0.8156394859007894,FUN_027938-T2,Peve_00032459,Pocillopora_meandrina_HIv1___RNAseq.g14030.t1,three_way,71.97066666666667,,,,,,,,,,,,,,,,,
OG_06187,0.2478623681993819,FUN_028099-T2,Peve_00004894,Pocillopora_meandrina_HIv1___RNAseq.g15574.t1,three_way,79.82566666666666,FUN_028099-T2,Q7ZUW2,,,,,57.3,913.0,4.6e-213,743.0,sp|Q7ZUW2|HYOU1_DANRE Hypoxia up-regulated protein 1 OS=Danio rerio OX=7955 GN=hyou1 PE=2 SV=1,,,,,,
OG_06257,0.2096940259918164,FUN_028275-T1,Peve_00000871,Pocillopora_meandrina_HIv1___RNAseq.g29777.t1,three_way,56.74166666666667,FUN_028275-T1,P49961,ENTP1_HUMAN,,Ectonucleoside triphosphate diphosphohydrolase 1 (EC 3.6.1.5) (ATP diphosphohydrolase) (ATP-DPH) (ATPDase) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoid cell activation antigen) (Nucleoside triphosphate diphosphohydrolase 1) (NTPDase1) (CD antigen CD39),Homo sapiens (Human),30.6,418.0,3e-43,177.6,sp|P49961|ENTP1_HUMAN Ectonucleoside triphosphate diphosphohydrolase 1 OS=Homo sapiens OX=9606 GN=ENTPD1 PE=1 SV=1,GO:0003924; GO:0004050; GO:0004382; GO:0005524; GO:0005604; GO:0005886; GO:0005901; GO:0007155; GO:0007186; GO:0007596; GO:0009134; GO:0009897; GO:0016020; GO:0016887; GO:0017110; GO:0017111; GO:0036384; GO:0043262; GO:0043273; GO:0045134; GO:0046032; GO:0070062; GO:0070527; GO:0103023; GO:1990003,ADP catabolic process [GO:0046032]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; G protein-coupled receptor signaling pathway [GO:0007186]; nucleoside diphosphate catabolic process [GO:0009134]; platelet aggregation [GO:0070527],basement membrane [GO:0005604]; caveola [GO:0005901]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886],ADP phosphatase activity [GO:0043262]; apyrase activity [GO:0004050]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; CDP phosphatase activity [GO:0036384]; CTPase activity [GO:0043273]; GDP phosphatase activity [GO:0004382]; GTPase activity [GO:0003924]; IDP phosphatase activity [GO:1990003]; ITPase activity [GO:0103023]; nucleoside diphosphate phosphatase activity [GO:0017110]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; UDP phosphatase activity [GO:0045134],GO:0003824; GO:0003924; GO:0005886; GO:0007155; GO:0016787; GO:0030312; GO:0031012; GO:0043226; GO:0055086; GO:1901135,catalytic activity; GTPase activity; plasma membrane; cell adhesion; hydrolase activity; external encapsulating structure; extracellular matrix; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_06260,0.1160511371818642,FUN_028278-T1,Peve_00003675,Pocillopora_meandrina_HIv1___RNAseq.g15498.t1,three_way,51.95133333333333,,,,,,,,,,,,,,,,,
OG_06276,0.1954623896734495,FUN_028315-T1,Peve_00040903,Pocillopora_meandrina_HIv1___TS.g11411.t1,three_way,55.938,FUN_028315-T1,P16092,FGFR1_MOUSE,,Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331),Mus musculus (Mouse),45.8,286.0,1.1e-67,259.2,sp|P16092|FGFR1_MOUSE Fibroblast growth factor receptor 1 OS=Mus musculus OX=10090 GN=Fgfr1 PE=1 SV=2,GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001837; GO:0002053; GO:0002062; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007420; GO:0007435; GO:0007605; GO:0008201; GO:0008283; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010468; GO:0010629; GO:0010966; GO:0010976; GO:0017134; GO:0021769; GO:0021847; GO:0030031; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0035607; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042803; GO:0043235; GO:0043536; GO:0043583; GO:0045666; GO:0045787; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048514; GO:0048699; GO:0048762; GO:0048863; GO:0050678; GO:0051174; GO:0051897; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0060979; GO:0070640; GO:0071344; GO:0071529; GO:0072089; GO:0090080; GO:0090272; GO:0090722; GO:0098794; GO:0098978; GO:0099151; GO:1903465; GO:1904383; GO:1905564; GO:2000648; GO:2000830; GO:2001028; GO:2001239,angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cementum mineralization [GO:0071529]; chondrocyte differentiation [GO:0002062]; diphosphate metabolic process [GO:0071344]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of epithelial cell proliferation [GO:0050678]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of postsynaptic density assembly [GO:0099151]; response to sodium phosphate [GO:1904383]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; ureteric bud development [GO:0001657]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0006629; GO:0016740; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; signaling; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_06297,0.2573441189940931,FUN_028497-T1,Peve_00019601,Pocillopora_meandrina_HIv1___RNAseq.g15239.t1,three_way,51.07533333333333,,,,,,,,,,,,,,,,,
OG_06305,0.4777030732043512,FUN_028511-T1,Peve_00008102,Pocillopora_meandrina_HIv1___RNAseq.g14117.t1,three_way,72.03616666666667,FUN_028511-T1,Q6GLC9,FMR1_XENTR,,Fragile X messenger ribonucleoprotein 1 homolog (XtFmrp),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),45.6,377.0,2e-87,324.7,sp|Q6GLC9|FMR1_XENTR Fragile X messenger ribonucleoprotein 1 homolog OS=Xenopus tropicalis OX=8364 GN=fmr1 PE=2 SV=1,GO:0000381; GO:0000775; GO:0002092; GO:0002151; GO:0003682; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006281; GO:0006397; GO:0006406; GO:0007215; GO:0007399; GO:0008017; GO:0008266; GO:0008380; GO:0010369; GO:0010494; GO:0010629; GO:0014069; GO:0017148; GO:0030371; GO:0030424; GO:0030425; GO:0030426; GO:0032433; GO:0033592; GO:0034046; GO:0034063; GO:0035195; GO:0035197; GO:0035198; GO:0035613; GO:0036464; GO:0042734; GO:0042803; GO:0042995; GO:0043005; GO:0043197; GO:0043204; GO:0043232; GO:0043488; GO:0043679; GO:0045202; GO:0045211; GO:0045727; GO:0045947; GO:0046928; GO:0046982; GO:0048027; GO:0048471; GO:0051028; GO:0051489; GO:0051491; GO:0060538; GO:0060965; GO:0060998; GO:0060999; GO:0070840; GO:0071598; GO:0097386; GO:0098793; GO:0098794; GO:0098908; GO:0140006; GO:0140693; GO:0140694; GO:1900453; GO:1901386; GO:1901800; GO:1902737; GO:1990247; GO:1990812; GO:1990825; GO:1990904; GO:2000301; GO:2000637; GO:2000766,"DNA repair [GO:0006281]; glutamate receptor signaling pathway [GO:0007215]; membraneless organelle assembly [GO:0140694]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of gene expression [GO:0010629]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of miRNA-mediated gene silencing [GO:0060965]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; nervous system development [GO:0007399]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of receptor internalization [GO:0002092]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]; regulation of neuronal action potential [GO:0098908]; regulation of neurotransmitter secretion [GO:0046928]; RNA splicing [GO:0008380]; skeletal muscle organ development [GO:0060538]; stress granule assembly [GO:0034063]","axon [GO:0030424]; axon terminus [GO:0043679]; cell projection [GO:0042995]; chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; filopodium tip [GO:0032433]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; intracellular membraneless organelle [GO:0043232]; neuron projection [GO:0043005]; neuronal ribonucleoprotein granule [GO:0071598]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]",chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; G-quadruplex RNA binding [GO:0002151]; histone H3 reader activity [GO:0140006]; microtubule binding [GO:0008017]; miRNA binding [GO:0035198]; molecular condensate scaffold activity [GO:0140693]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; sequence-specific mRNA binding [GO:1990825]; siRNA binding [GO:0035197]; translation repressor activity [GO:0030371],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006281; GO:0006913; GO:0008092; GO:0016071; GO:0016853; GO:0031047; GO:0043226; GO:0045182; GO:0048856; GO:0060090; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA repair; nucleocytoplasmic transport; cytoskeletal protein binding; mRNA metabolic process; isomerase activity; regulatory ncRNA-mediated gene silencing; organelle; translation regulator activity; anatomical structure development; molecular adaptor activity; catalytic activity, acting on RNA"
OG_06353,0.6262553609184285,FUN_028946-T1,Peve_00026868,Pocillopora_meandrina_HIv1___RNAseq.g25583.t1,three_way,40.32216666666666,,,,,,,,,,,,,,,,,
OG_06371,0.3879839770049997,FUN_028976-T1,Peve_00016207,Pocillopora_meandrina_HIv1___RNAseq.g25603.t1,three_way,67.631,FUN_028976-T1,Q8IXL7,MSRB3_HUMAN,,Methionine-R-sulfoxide reductase B3 (MsrB3) (EC 1.8.4.12) (EC 1.8.4.14),Homo sapiens (Human),57.7,137.0,7.799999999999999e-46,184.9,sp|Q8IXL7|MSRB3_HUMAN Methionine-R-sulfoxide reductase B3 OS=Homo sapiens OX=9606 GN=MSRB3 PE=1 SV=2,GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006979; GO:0008270; GO:0030091; GO:0033743; GO:0033745,protein repair [GO:0030091]; response to oxidative stress [GO:0006979],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739],L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0005783; GO:0005829; GO:0016491; GO:0043226,catalytic activity; mitochondrion; endoplasmic reticulum; cytosol; oxidoreductase activity; organelle
OG_06417,0.3496258374662718,FUN_029104-T1,Peve_00038072,Pocillopora_meandrina_HIv1___TS.g8929.t1,three_way,65.834,FUN_029104-T1,P41970,ELK3_HUMAN,,ETS domain-containing protein Elk-3 (ETS-related protein ERP) (ETS-related protein NET) (Serum response factor accessory protein 2) (SAP-2) (SRF accessory protein 2),Homo sapiens (Human),60.0,85.0,1.5000000000000002e-22,107.8,sp|P41970|ELK3_HUMAN ETS domain-containing protein Elk-3 OS=Homo sapiens OX=9606 GN=ELK3 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0007165; GO:0030154; GO:0032422; GO:0042060; GO:0045944; GO:1990837,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; wound healing [GO:0042060],chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006355; GO:0030154; GO:0042060; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; mitochondrion; regulation of DNA-templated transcription; cell differentiation; wound healing; organelle; transcription regulator activity
OG_06423,0.2303275674817348,FUN_029112-T1,Peve_00013128,Pocillopora_meandrina_HIv1___RNAseq.g25756.t1,three_way,93.785,FUN_029112-T1,O60830,TI17B_HUMAN,,Mitochondrial import inner membrane translocase subunit Tim17-B,Homo sapiens (Human),66.5,167.0,3.3e-55,216.1,sp|O60830|TI17B_HUMAN Mitochondrial import inner membrane translocase subunit Tim17-B OS=Homo sapiens OX=9606 GN=TIMM17B PE=1 SV=1,GO:0005739; GO:0005743; GO:0005744; GO:0006626; GO:0006886; GO:0008320; GO:0030150,intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744],protein transmembrane transporter activity [GO:0008320],GO:0005215; GO:0005739; GO:0006886; GO:0043226; GO:0055085,transporter activity; mitochondrion; intracellular protein transport; organelle; transmembrane transport
OG_06425,0.2445014950168581,FUN_029114-T1,Peve_00013130,Pocillopora_meandrina_HIv1___RNAseq.g25758.t1,three_way,83.05566666666667,FUN_029114-T1,P18294,,,,,61.8,1211.0,0.0,1511.1,"sp|P18294|KCRF_STRPU Creatine kinase, flagellar OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=1",,,,,,
OG_06434,0.2452261251428179,FUN_029128-T1,Peve_00004674,Pocillopora_meandrina_HIv1___RNAseq.g25780.t1,three_way,76.54333333333334,FUN_029128-T1,I6V1W0,,,,,40.1,409.0,1.2e-79,298.9,sp|I6V1W0|BMBL_DANRE Protein brambleberry OS=Danio rerio OX=7955 GN=bmb PE=2 SV=1,,,,,,
OG_06436,0.6183561778855353,FUN_029130-T1,Peve_00033155,Pocillopora_meandrina_HIv1___RNAseq.g25785.t1,three_way,48.33016666666666,,,,,,,,,,,,,,,,,
OG_06477,0.1661037846280013,FUN_029244-T1,Peve_00013750,Pocillopora_meandrina_HIv1___TS.g8847.t1b,three_way,82.03566666666667,FUN_029244-T1,A2RUV5,,,,,60.9,727.0,4.3999999999999996e-259,896.0,sp|A2RUV5|HFM1_XENTR Probable ATP-dependent DNA helicase HFM1 OS=Xenopus tropicalis OX=8364 GN=hfm1 PE=2 SV=1,,,,,,
OG_06657,0.3145601683965421,FUN_030873-T1,Peve_00043626,Pocillopora_meandrina_HIv1___RNAseq.g30288.t1,three_way,63.519333333333336,,,,,,,,,,,,,,,,,
OG_06708,0.3510256430543791,FUN_031289-T1,Peve_00026529,Pocillopora_meandrina_HIv1___RNAseq.g5169.t1,three_way,74.811,FUN_031289-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),58.3,599.0,8.2e-179,629.8,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_06891,0.6764254595730705,FUN_031930-T1,Peve_00004237,Pocillopora_meandrina_HIv1___RNAseq.g18237.t1,three_way,54.86833333333333,,,,,,,,,,,,,,,,,
OG_07000,0.3894526351900755,FUN_032151-T1,Peve_00003236,Pocillopora_meandrina_HIv1___RNAseq.g5328.t1,three_way,63.626333333333335,FUN_032151-T1,Q9NPA2,MMP25_HUMAN,,Matrix metalloproteinase-25 (MMP-25) (EC 3.4.24.-) (Leukolysin) (Membrane-type matrix metalloproteinase 6) (MT-MMP 6) (MTMMP6) (Membrane-type-6 matrix metalloproteinase) (MT6-MMP) (MT6MMP),Homo sapiens (Human),36.2,384.0,6.7e-56,219.9,sp|Q9NPA2|MMP25_HUMAN Matrix metalloproteinase-25 OS=Homo sapiens OX=9606 GN=MMP25 PE=1 SV=1,GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0006954; GO:0008270; GO:0016020; GO:0030198; GO:0030574; GO:0031012; GO:0035579; GO:0060022; GO:0098552,collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; hard palate development [GO:0060022]; inflammatory response [GO:0006954]; proteolysis [GO:0006508],extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; specific granule membrane [GO:0035579],metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0006954; GO:0016787; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0140096,"catalytic activity; extracellular space; plasma membrane; inflammatory response; hydrolase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; catalytic activity, acting on a protein"
OG_07016,0.4139234255031896,FUN_032192-T1,Peve_00020047,Pocillopora_meandrina_HIv1___RNAseq.g24665.t1,three_way,77.12066666666666,,,,,,,,,,,,,,,,,
OG_07036,0.2280227877457112,FUN_032231-T1,Peve_00043435,Pocillopora_meandrina_HIv1___RNAseq.g24834.t1,three_way,85.91533333333334,FUN_032231-T1,Q2KIN6,,,,,40.7,172.0,1.8999999999999998e-35,150.6,sp|Q2KIN6|MPV17_BOVIN Mitochondrial inner membrane protein Mpv17 OS=Bos taurus OX=9913 GN=MPV17 PE=2 SV=1,,,,,,
OG_07121,0.4354889063471495,FUN_032420-T1,Peve_00041753,Pocillopora_meandrina_HIv1___RNAseq.g24395.t1,three_way,71.22583333333333,,,,,,,,,,,,,,,,,
OG_07134,0.624017276992502,FUN_032459-T1,Peve_00009149,Pocillopora_meandrina_HIv1___RNAseq.g24151.t1,three_way,75.24633333333333,,,,,,,,,,,,,,,,,
OG_07240,0.0952735672087014,FUN_032970-T1,Peve_00015579,Pocillopora_meandrina_HIv1___RNAseq.g24965.t1,three_way,86.36466666666666,FUN_032970-T1,P86884,,,,,77.8,374.0,5e-178,625.2,sp|P86884|ADHX_SCYCA Alcohol dehydrogenase class-3 OS=Scyliorhinus canicula OX=7830 PE=1 SV=1,,,,,,
OG_07346,0.2569608961415592,FUN_033753-T1,Peve_00004935,Pocillopora_meandrina_HIv1___RNAseq.g28751.t1,three_way,71.35733333333333,FUN_033753-T1,Q8MPM1,,,,,51.9,362.0,3.4e-99,363.2,sp|Q8MPM1|GELS2_LUMTE Gelsolin-like protein 2 OS=Lumbricus terrestris OX=6398 GN=gelsolin PE=1 SV=1,,,,,,
OG_07394,0.5003275236303271,FUN_033824-T1,Peve_00028770,Pocillopora_meandrina_HIv1___RNAseq.g26355.t1,three_way,53.976,,,,,,,,,,,,,,,,,
OG_07435,0.3138590437749688,FUN_033924-T1,Peve_00022623,Pocillopora_meandrina_HIv1___RNAseq.g26586.t2,three_way,66.44966666666667,FUN_033924-T1,Q14444,CAPR1_HUMAN,,Caprin-1 (Cell cycle-associated protein 1) (Cytoplasmic activation- and proliferation-associated protein 1) (GPI-anchored membrane protein 1) (GPI-anchored protein p137) (GPI-p137) (p137GPI) (Membrane component chromosome 11 surface marker 1) (RNA granule protein 105),Homo sapiens (Human),38.3,180.0,4.2e-27,123.2,sp|Q14444|CAPR1_HUMAN Caprin-1 OS=Homo sapiens OX=9606 GN=CAPRIN1 PE=1 SV=2,GO:0000932; GO:0003723; GO:0003729; GO:0005524; GO:0005737; GO:0005829; GO:0007416; GO:0008298; GO:0010494; GO:0016020; GO:0017148; GO:0030027; GO:0030425; GO:0031252; GO:0035591; GO:0043232; GO:0045202; GO:0048699; GO:0050775; GO:0061003; GO:0062029; GO:0106288; GO:0140677; GO:0140693; GO:0140694,generation of neurons [GO:0048699]; intracellular mRNA localization [GO:0008298]; membraneless organelle assembly [GO:0140694]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of stress granule assembly [GO:0062029]; regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0106288]; synapse assembly [GO:0007416],cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membraneless organelle [GO:0043232]; lamellipodium [GO:0030027]; membrane [GO:0016020]; P-body [GO:0000932]; synapse [GO:0045202],ATP binding [GO:0005524]; molecular condensate scaffold activity [GO:0140693]; molecular function activator activity [GO:0140677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; signaling adaptor activity [GO:0035591],GO:0003723; GO:0005829; GO:0030154; GO:0034330; GO:0043226; GO:0060090; GO:0098772,RNA binding; cytosol; cell differentiation; cell junction organization; organelle; molecular adaptor activity; molecular function regulator activity
OG_07503,0.3611576925779376,FUN_034043-T1,Peve_00023163,Pocillopora_meandrina_HIv1___RNAseq.g26041.t1,three_way,35.382666666666665,,,,,,,,,,,,,,,,,
OG_07620,0.1240742272799007,FUN_034361-T1,Peve_00036161,Pocillopora_meandrina_HIv1___TS.g18876.t2,three_way,81.43766666666667,FUN_034361-T1,B5X4E0,,,,,58.0,319.0,1.3e-92,341.3,sp|B5X4E0|CALUB_SALSA Calumenin-B OS=Salmo salar OX=8030 GN=calub PE=2 SV=1,,,,,,
OG_07636,0.2210325649055101,FUN_034395-T1,Peve_00002462,Pocillopora_meandrina_HIv1___RNAseq.g26668.t1,three_way,63.63366666666666,,,,,,,,,,,,,,,,,
OG_07640,0.177026945907437,FUN_034418-T1,Peve_00033057,Pocillopora_meandrina_HIv1___RNAseq.g28578.t1,three_way,49.98766666666667,FUN_034418-T1,Q766D5,,,,,39.9,323.0,1.6e-68,262.3,sp|Q766D5|B4GN4_MOUSE N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 OS=Mus musculus OX=10090 GN=B4galnt4 PE=2 SV=1,,,,,,
OG_07705,0.5127571660211734,FUN_034843-T1,Peve_00037378,Pocillopora_meandrina_HIv1___RNAseq.g27195.t1,three_way,68.62916666666666,FUN_034843-T1,A5D8S5,SH3R1_DANRE,,E3 ubiquitin-protein ligase SH3RF1 (EC 2.3.2.27) (Plenty of SH3s) (Protein POSH) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1),Danio rerio (Zebrafish) (Brachydanio rerio),39.0,77.0,6.6e-06,53.9,sp|A5D8S5|SH3R1_DANRE E3 ubiquitin-protein ligase SH3RF1 OS=Danio rerio OX=7955 GN=sh3rf1 PE=2 SV=2,GO:0001764; GO:0005078; GO:0005794; GO:0008270; GO:0016567; GO:0030027; GO:0032436; GO:0043066; GO:0043370; GO:0046330; GO:0048471; GO:0051865; GO:0061630; GO:2000564,"negative regulation of apoptotic process [GO:0043066]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]",Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471],MAP-kinase scaffold activity [GO:0005078]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005794; GO:0016740; GO:0043226; GO:0048870; GO:0060090; GO:0140096,"catalytic activity; Golgi apparatus; transferase activity; organelle; cell motility; molecular adaptor activity; catalytic activity, acting on a protein"
OG_07778,0.277565744073827,FUN_034994-T1,Peve_00024604,Pocillopora_meandrina_HIv1___TS.g3464.t1,three_way,66.411,FUN_034994-T1,O02667,,,,,24.4,308.0,6.8e-18,93.2,sp|O02667|AA3R_RABIT Adenosine receptor A3 OS=Oryctolagus cuniculus OX=9986 GN=ADORA3 PE=2 SV=1,,,,,,
OG_07872,0.3641269229365367,FUN_035231-T1,Peve_00044486,Pocillopora_meandrina_HIv1___RNAseq.g27905.t1,three_way,73.57433333333333,,,,,,,,,,,,,,,,,
OG_07912,0.4691388708377899,FUN_035371-T1,Peve_00016216,Pocillopora_meandrina_HIv1___RNAseq.g12225.t1,three_way,67.83666666666667,,,,,,,,,,,,,,,,,
OG_07914,0.2934530117730128,FUN_035393-T1,Peve_00005174,Pocillopora_meandrina_HIv1___RNAseq.g12212.t1,three_way,60.65866666666667,,,,,,,,,,,,,,,,,
OG_07917,0.1704775686022628,FUN_035401-T1,Peve_00002636,Pocillopora_meandrina_HIv1___TS.g3525.t1,three_way,60.43566666666666,FUN_035401-T1,Q8R0N9,ZDHC1_MOUSE,,Palmitoyltransferase ZDHHC1 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 1),Mus musculus (Mouse),49.4,267.0,2.7e-41,171.4,sp|Q8R0N9|ZDHC1_MOUSE Palmitoyltransferase ZDHHC1 OS=Mus musculus OX=10090 GN=Zdhhc1 PE=1 SV=2,GO:0002230; GO:0005789; GO:0005794; GO:0010008; GO:0016409; GO:0018230; GO:0019706; GO:0032461; GO:0140374; GO:1900227; GO:1905668,antiviral innate immune response [GO:0140374]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of protein localization to endosome [GO:1905668]; positive regulation of protein oligomerization [GO:0032461],endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794],palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706],GO:0002376; GO:0003824; GO:0005794; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; Golgi apparatus; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_07935,0.3605796017005874,FUN_035439-T1,Peve_00037156,Pocillopora_meandrina_HIv1___RNAseq.g27578.t1,three_way,43.833333333333336,,,,,,,,,,,,,,,,,
OG_08034,0.3474263245684896,FUN_035694-T1,Peve_00033765,Pocillopora_meandrina_HIv1___RNAseq.g11819.t1,three_way,79.92699999999999,FUN_035694-T1,Q8BQM4,,,,,35.3,680.0,4.0999999999999996e-92,340.5,sp|Q8BQM4|HEAT3_MOUSE HEAT repeat-containing protein 3 OS=Mus musculus OX=10090 GN=Heatr3 PE=1 SV=1,,,,,,
OG_08096,0.47026157624223,FUN_035837-T1,Peve_00032517,Pocillopora_meandrina_HIv1___RNAseq.g11959.t1,three_way,60.47533333333333,FUN_035837-T1,Q16820,,,,,34.7,380.0,1.9e-53,213.0,sp|Q16820|MEP1B_HUMAN Meprin A subunit beta OS=Homo sapiens OX=9606 GN=MEP1B PE=1 SV=3,,,,,,
OG_08097,0.8740556168014346,FUN_035839-T1,Peve_00032500,Pocillopora_meandrina_HIv1___RNAseq.g11958.t2,three_way,68.27866666666667,,,,,,,,,,,,,,,,,
OG_08098,0.8955279600834235,FUN_035840-T1,Peve_00032502,Pocillopora_meandrina_HIv1___RNAseq.g11957.t1,three_way,76.54033333333332,FUN_035840-T1,P38532,HSF1_MOUSE,,Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1),Mus musculus (Mouse),55.7,176.0,1.1e-44,182.6,sp|P38532|HSF1_MOUSE Heat shock factor protein 1 OS=Mus musculus OX=10090 GN=Hsf1 PE=1 SV=2,GO:0000122; GO:0000165; GO:0000776; GO:0000791; GO:0000792; GO:0000978; GO:0001162; GO:0001227; GO:0001228; GO:0001701; GO:0001892; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006397; GO:0006952; GO:0007143; GO:0007283; GO:0007584; GO:0008283; GO:0009408; GO:0010628; GO:0010667; GO:0014823; GO:0016605; GO:0019901; GO:0031072; GO:0031333; GO:0031490; GO:0032496; GO:0032720; GO:0032991; GO:0033574; GO:0034605; GO:0034620; GO:0035865; GO:0040018; GO:0042802; GO:0043565; GO:0045120; GO:0045651; GO:0045931; GO:0045944; GO:0046982; GO:0048471; GO:0050673; GO:0050680; GO:0051028; GO:0051879; GO:0060136; GO:0061770; GO:0062029; GO:0065003; GO:0070301; GO:0071222; GO:0071276; GO:0071280; GO:0071392; GO:0071466; GO:0071480; GO:0072738; GO:0090084; GO:0090261; GO:0097165; GO:0097431; GO:0097677; GO:0098847; GO:0101031; GO:0120162; GO:0140296; GO:1900034; GO:1901652; GO:1902512; GO:1903936; GO:1904385; GO:1904843; GO:1904845; GO:1990841; GO:1990904; GO:1990910; GO:1990911; GO:2001033; GO:2001235,cell population proliferation [GO:0008283]; cellular response to angiotensin [GO:1904385]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to estradiol stimulus [GO:0071392]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamine [GO:1904845]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitroglycerin [GO:1904843]; cellular response to potassium ion [GO:0035865]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; defense response [GO:0006952]; DNA repair [GO:0006281]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; epithelial cell proliferation [GO:0050673]; female meiotic nuclear division [GO:0007143]; in utero embryonic development [GO:0001701]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress granule assembly [GO:0062029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; response to activity [GO:0014823]; response to heat [GO:0009408]; response to hypobaric hypoxia [GO:1990910]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to peptide [GO:1901652]; response to psychosocial stress [GO:1990911]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; pronucleus [GO:0045120]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; general transcription initiation factor binding [GO:0140296]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; sequence-specific single stranded DNA binding [GO:0098847]; STAT family protein binding [GO:0097677]; translation elongation factor binding [GO:0061770]",GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006355; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0065003; GO:0140013; GO:0140110,DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA repair; regulation of DNA-templated transcription; mRNA metabolic process; reproductive process; organelle; anatomical structure development; protein-containing complex assembly; meiotic nuclear division; transcription regulator activity
OG_08218,0.4114708322809349,FUN_036079-T1,Peve_00018984,Pocillopora_meandrina_HIv1___RNAseq.g27415.t1,three_way,56.51533333333333,,,,,,,,,,,,,,,,,
OG_08309,0.356000930255913,FUN_036334-T1,Peve_00031396,Pocillopora_meandrina_HIv1___RNAseq.g12103.t1,three_way,81.12233333333333,,,,,,,,,,,,,,,,,
OG_08311,0.5070522635147464,FUN_036338-T1,Peve_00031393,Pocillopora_meandrina_HIv1___RNAseq.g12116.t1,three_way,98.718,FUN_036338-T1,Q6PBJ2,CFA20_DANRE,,Cilia- and flagella-associated protein 20,Danio rerio (Zebrafish) (Brachydanio rerio),98.1,156.0,3e-84,312.4,sp|Q6PBJ2|CFA20_DANRE Cilia- and flagella-associated protein 20 OS=Danio rerio OX=7955 GN=cfap20 PE=2 SV=1,GO:0001895; GO:0005634; GO:0005814; GO:0005879; GO:0005929; GO:0014807; GO:0018095; GO:0031514; GO:0036064; GO:0048570; GO:0060271; GO:0060296; GO:0061371; GO:0065001; GO:1901207; GO:2000147; GO:2000253,cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; notochord morphogenesis [GO:0048570]; positive regulation of cell motility [GO:2000147]; positive regulation of feeding behavior [GO:2000253]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of heart looping [GO:1901207]; regulation of somitogenesis [GO:0014807]; retina homeostasis [GO:0001895]; specification of axis polarity [GO:0065001],axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; motile cilium [GO:0031514]; nucleus [GO:0005634],,GO:0005634; GO:0005815; GO:0005929; GO:0043226; GO:0044782,nucleus; microtubule organizing center; cilium; organelle; cilium organization
OG_08337,0.7588807495943674,FUN_036850-T1,Peve_00036530,Pocillopora_meandrina_HIv1___RNAseq.g10652.t1,three_way,46.763666666666666,,,,,,,,,,,,,,,,,
OG_08367,0.1815849580352964,FUN_036919-T1,Peve_00018354,Pocillopora_meandrina_HIv1___RNAseq.g10824.t1,three_way,88.945,FUN_036919-T1,Q8BWT1,THIM_MOUSE,,"3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-, EC 3.1.2.1, EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase)",Mus musculus (Mouse),65.7,394.0,5.2e-149,528.9,"sp|Q8BWT1|THIM_MOUSE 3-ketoacyl-CoA thiolase, mitochondrial OS=Mus musculus OX=10090 GN=Acaa2 PE=1 SV=3",GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0005743; GO:0006635; GO:0016604; GO:0036064; GO:0047617; GO:0071456; GO:1901029; GO:1902109,cellular response to hypoxia [GO:0071456]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029],ciliary basal body [GO:0036064]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604],acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; fatty acyl-CoA hydrolase activity [GO:0047617],GO:0003824; GO:0005739; GO:0005815; GO:0006629; GO:0007005; GO:0016740; GO:0016787; GO:0043226; GO:0061024,catalytic activity; mitochondrion; microtubule organizing center; lipid metabolic process; mitochondrion organization; transferase activity; hydrolase activity; organelle; membrane organization
OG_08460,0.1181000438291836,FUN_037229-T1,Peve_00006216,Pocillopora_meandrina_HIv1___RNAseq.g11032.t1,three_way,76.78283333333334,FUN_037229-T1,B6D5P3,DAAF1_PERLE,,Dynein axonemal assembly factor 1 (Leucine-rich repeat-containing protein 50),Peromyscus leucopus (White-footed mouse),53.7,326.0,1.7e-26,122.5,sp|B6D5P3|DAAF1_PERLE Dynein axonemal assembly factor 1 OS=Peromyscus leucopus OX=10041 GN=Dnaaf1 PE=2 SV=1,GO:0005930; GO:0035082; GO:0060271; GO:0070840,axoneme assembly [GO:0035082]; cilium assembly [GO:0060271],axoneme [GO:0005930],dynein complex binding [GO:0070840],GO:0007010; GO:0044782,cytoskeleton organization; cilium organization
OG_08484,0.6246294429621269,FUN_037320-T1,Peve_00006220,Pocillopora_meandrina_HIv1___RNAseq.g10703.t1,three_way,66.359,FUN_037320-T1,A2VE04,FRRS1_BOVIN,,Ferric-chelate reductase 1 (EC 1.-.-.-),Bos taurus (Bovine),29.7,202.0,6.1e-07,57.4,sp|A2VE04|FRRS1_BOVIN Ferric-chelate reductase 1 OS=Bos taurus OX=9913 GN=FRRS1 PE=2 SV=1,GO:0006879; GO:0016020; GO:0016722; GO:0046872,intracellular iron ion homeostasis [GO:0006879],membrane [GO:0016020],"metal ion binding [GO:0046872]; oxidoreductase activity, acting on metal ions [GO:0016722]",GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_08614,0.6455849233549678,FUN_037761-T1,Peve_00014333,Pocillopora_meandrina_HIv1___RNAseq.g1495.t2a,three_way,37.405,,,,,,,,,,,,,,,,,
OG_08879,0.2725037402526343,FUN_038279-T1,Peve_00041709,Pocillopora_meandrina_HIv1___RNAseq.g28314.t1,three_way,89.11583333333333,FUN_038279-T1,Q4G0X9,CCD40_HUMAN,,Coiled-coil domain-containing protein 40,Homo sapiens (Human),30.7,969.0,3.8e-100,367.9,sp|Q4G0X9|CCD40_HUMAN Coiled-coil domain-containing protein 40 OS=Homo sapiens OX=9606 GN=CCDC40 PE=1 SV=2,GO:0001947; GO:0003341; GO:0003351; GO:0003356; GO:0005576; GO:0005737; GO:0005929; GO:0005930; GO:0030317; GO:0030324; GO:0031514; GO:0035082; GO:0035469; GO:0036159; GO:0044458; GO:0060287; GO:0061512; GO:0070286; GO:0071907; GO:0071910,axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency [GO:0003356],axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514],,GO:0005576; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0065003,extracellular region; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; cilium organization; anatomical structure development; cell motility; protein-containing complex assembly
OG_08911,0.3437526696553727,FUN_038345-T1,Peve_00000092,Pocillopora_meandrina_HIv1___RNAseq.g1104.t1,three_way,95.93,FUN_038345-T1,A4IHR1,IT70A_XENTR,,Intraflagellar transport protein 70A (Tetratricopeptide repeat protein 30A) (TPR repeat protein 30A),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),78.8,646.0,2e-307,1055.8,sp|A4IHR1|IT70A_XENTR Intraflagellar transport protein 70A OS=Xenopus tropicalis OX=8364 GN=ift70a PE=2 SV=1,GO:0001501; GO:0001822; GO:0005879; GO:0005929; GO:0018095; GO:0042073; GO:0060271,cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; protein polyglutamylation [GO:0018095]; skeletal system development [GO:0001501],axonemal microtubule [GO:0005879]; cilium [GO:0005929],,GO:0005929; GO:0007018; GO:0043226; GO:0044782; GO:0048856,cilium; microtubule-based movement; organelle; cilium organization; anatomical structure development
OG_08975,0.7633139359452713,FUN_038482-T1,Peve_00013523,Pocillopora_meandrina_HIv1___RNAseq.g6991.t1,three_way,43.61266666666667,,,,,,,,,,,,,,,,,
OG_08984,0.6118458883005313,FUN_038503-T1,Peve_00041694,Pocillopora_meandrina_HIv1___RNAseq.g28159.t1,three_way,62.70366666666667,,,,,,,,,,,,,,,,,
OG_08988,0.4139110108747069,FUN_038508-T1,Peve_00041683,Pocillopora_meandrina_HIv1___RNAseq.g28175.t1,three_way,84.98566666666667,FUN_038508-T1,P10644,KAP0_HUMAN,,cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1) (TSE1),Homo sapiens (Human),70.1,374.0,1.1e-140,501.1,sp|P10644|KAP0_HUMAN cAMP-dependent protein kinase type I-alpha regulatory subunit OS=Homo sapiens OX=9606 GN=PRKAR1A PE=1 SV=1,GO:0001707; GO:0004862; GO:0005737; GO:0005771; GO:0005813; GO:0005829; GO:0005952; GO:0006357; GO:0007189; GO:0008603; GO:0010629; GO:0016020; GO:0019904; GO:0030552; GO:0031588; GO:0031594; GO:0031625; GO:0032024; GO:0032991; GO:0034236; GO:0035556; GO:0044853; GO:0045214; GO:0046007; GO:0060038; GO:0071377; GO:0097546; GO:0098978; GO:0120212; GO:0141162,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cardiac muscle cell proliferation [GO:0060038]; cellular response to glucagon stimulus [GO:0071377]; intracellular signal transduction [GO:0035556]; mesoderm formation [GO:0001707]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of gene expression [GO:0010629]; positive regulation of insulin secretion [GO:0032024]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214],cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; multivesicular body [GO:0005771]; neuromuscular junction [GO:0031594]; nucleotide-activated protein kinase complex [GO:0031588]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; sperm head-tail coupling apparatus [GO:0120212],cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein domain specific binding [GO:0019904]; protein kinase A catalytic subunit binding [GO:0034236]; ubiquitin protein ligase binding [GO:0031625],GO:0005768; GO:0005815; GO:0005829; GO:0006355; GO:0007010; GO:0031410; GO:0043226; GO:0098772,endosome; microtubule organizing center; cytosol; regulation of DNA-templated transcription; cytoskeleton organization; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_08990,0.3577552533636913,FUN_038512-T1,Peve_00041679,Pocillopora_meandrina_HIv1___RNAseq.20620_t,three_way,87.99716666666667,FUN_038512-T1,Q6P1M3,L2GL2_HUMAN,,LLGL scribble cell polarity complex component 2 (HGL) (Lethal(2) giant larvae protein homolog 2),Homo sapiens (Human),41.5,959.0,1.6e-203,711.4,sp|Q6P1M3|L2GL2_HUMAN LLGL scribble cell polarity complex component 2 OS=Homo sapiens OX=9606 GN=LLGL2 PE=1 SV=2,GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0006887; GO:0006893; GO:0008593; GO:0009791; GO:0015820; GO:0016332; GO:0030165; GO:0030864; GO:0030866; GO:0032878; GO:0035264; GO:0043231; GO:0045159; GO:0045197; GO:0051294; GO:0051301; GO:0060670; GO:0060716,branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; L-leucine transport [GO:0015820]; labyrinthine layer blood vessel development [GO:0060716]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593],adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165],GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0043226; GO:0048856; GO:0098772,cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; organelle; anatomical structure development; molecular function regulator activity
OG_09008,0.2772841879172851,FUN_038565-T1,Peve_00020185,Pocillopora_meandrina_HIv1___RNAseq.g1021.t1,three_way,72.52799999999999,FUN_038565-T1,Q8C5H1,ANO4_MOUSE,,Anoctamin-4 (Transmembrane protein 16D),Mus musculus (Mouse),36.6,846.0,1.5e-148,528.5,sp|Q8C5H1|ANO4_MOUSE Anoctamin-4 OS=Mus musculus OX=10090 GN=Ano4 PE=1 SV=2,GO:0005886; GO:0017128; GO:0046983; GO:0051649; GO:0061589; GO:0061590; GO:0061591; GO:1902476,calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; establishment of localization in cell [GO:0051649],plasma membrane [GO:0005886],phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0055085; GO:0061024,transporter activity; plasma membrane; transmembrane transport; membrane organization
OG_09120,0.6899320558258362,FUN_039266-T1,Peve_00002772,Pocillopora_meandrina_HIv1___RNAseq.g13577.t1,three_way,76.14266666666667,FUN_039266-T1,P12394,,,,,43.7,462.0,3.8999999999999998e-109,396.7,"sp|P12394|CP17A_CHICK Steroid 17-alpha-hydroxylase/17,20 lyase OS=Gallus gallus OX=9031 GN=CYP17A1 PE=2 SV=1",,,,,,
OG_09132,0.0854084168305399,FUN_039607-T1,Peve_00035010,Pocillopora_meandrina_HIv1___RNAseq.g5325.t1,three_way,91.42866666666669,,,,,,,,,,,,,,,,,
OG_09146,0.2710327768059387,FUN_039798-T1,Peve_00017577,Pocillopora_meandrina_HIv1___RNAseq.g7474.t1,three_way,69.27600000000001,,,,,,,,,,,,,,,,,
OG_09216,0.6356131604543083,FUN_039935-T1,Peve_00036234,Pocillopora_meandrina_HIv1___RNAseq.g7328.t1,three_way,60.9255,FUN_039935-T1,Q3TLH4,,,,,29.5,451.0,5.8e-24,116.3,sp|Q3TLH4|PRC2C_MOUSE Protein PRRC2C OS=Mus musculus OX=10090 GN=Prrc2c PE=1 SV=3,,,,,,
OG_09286,0.3262964151250209,FUN_040107-T1,Peve_00037281,Pocillopora_meandrina_HIv1___RNAseq.g8724.t1,three_way,86.47783333333334,FUN_040107-T1,Q0VCX2,BIP_BOVIN,,Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein),Bos taurus (Bovine),83.2,637.0,9.8e-294,1010.4,sp|Q0VCX2|BIP_BOVIN Endoplasmic reticulum chaperone BiP OS=Bos taurus OX=9913 GN=HSPA5 PE=2 SV=1,GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005788; GO:0005789; GO:0005793; GO:0005829; GO:0005886; GO:0006983; GO:0008180; GO:0009986; GO:0016020; GO:0016887; GO:0019904; GO:0021589; GO:0021680; GO:0030291; GO:0030335; GO:0030496; GO:0030512; GO:0030968; GO:0031072; GO:0031204; GO:0031333; GO:0031398; GO:0031625; GO:0034663; GO:0035437; GO:0036503; GO:0042026; GO:0042149; GO:0042470; GO:0043022; GO:0043066; GO:0043231; GO:0044183; GO:0051085; GO:0051787; GO:0071353; GO:0140662; GO:1903895; GO:1903898,"cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell migration [GO:0030335]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein targeting to membrane, translocation [GO:0031204]; protein refolding [GO:0042026]",cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; protein serine/threonine kinase inhibitor activity [GO:0030291]; ribosome binding [GO:0043022]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006457; GO:0006886; GO:0016787; GO:0030163; GO:0031410; GO:0043226; GO:0044183; GO:0048856; GO:0055085; GO:0098772; GO:0140657,catalytic activity; nucleus; mitochondrion; cytosol; plasma membrane; protein folding; intracellular protein transport; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle; protein folding chaperone; anatomical structure development; transmembrane transport; molecular function regulator activity; ATP-dependent activity
OG_09440,0.6455778579718973,FUN_041426-T1,Peve_00008987,Pocillopora_meandrina_HIv1___RNAseq.g15735.t2,three_way,80.48633333333333,FUN_041426-T1,P97360,ETV6_MOUSE,,Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel),Mus musculus (Mouse),44.6,65.0,1.7e-11,70.9,sp|P97360|ETV6_MOUSE Transcription factor ETV6 OS=Mus musculus OX=10090 GN=Etv6 PE=1 SV=1,GO:0000978; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005730; GO:0005829; GO:0006355; GO:0007296; GO:0019904; GO:0022008; GO:0030154; GO:0045944; GO:0071425; GO:0097152,cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; mesenchymal cell apoptotic process [GO:0097152]; neurogenesis [GO:0022008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; vitellogenesis [GO:0007296],cytosol [GO:0005829]; nucleolus [GO:0005730],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005730; GO:0005829; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleolus; cytosol; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; transcription regulator activity
OG_09530,0.614667599514181,FUN_041607-T1,Peve_00026860,Pocillopora_meandrina_HIv1___RNAseq.g15307.t1,three_way,78.76933333333334,FUN_041607-T1,P49748,ACADV_HUMAN,,"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (VLCAD) (EC 1.3.8.9)",Homo sapiens (Human),64.5,595.0,5.3e-212,738.8,"sp|P49748|ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ACADVL PE=1 SV=1",GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0005759; GO:0009409; GO:0015980; GO:0017099; GO:0030855; GO:0031966; GO:0033539; GO:0042645; GO:0042802; GO:0045717; GO:0046322; GO:0050660; GO:0090181,energy derivation by oxidation of organic compounds [GO:0015980]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain fatty acyl-CoA dehydrogenase activity [GO:0017099],GO:0003824; GO:0005654; GO:0005730; GO:0005739; GO:0006091; GO:0006629; GO:0008289; GO:0016491; GO:0030154; GO:0043226,catalytic activity; nucleoplasm; nucleolus; mitochondrion; generation of precursor metabolites and energy; lipid metabolic process; lipid binding; oxidoreductase activity; cell differentiation; organelle
OG_09596,0.8196423735852834,FUN_041743-T1,Peve_00002188,Pocillopora_meandrina_HIv1___RNAseq.g15788.t1,three_way,64.87933333333334,,,,,,,,,,,,,,,,,
OG_09626,0.2389604592843839,FUN_041790-T1,Peve_00038533,Pocillopora_meandrina_HIv1___RNAseq.g15769.t1,three_way,61.01483333333333,FUN_041790-T1,Q8TE57,ATS16_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),Homo sapiens (Human),30.0,1013.0,6.7e-112,407.1,sp|Q8TE57|ATS16_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Homo sapiens OX=9606 GN=ADAMTS16 PE=1 SV=3,GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; catalytic activity, acting on a protein"
OG_09750,0.2907231931174128,FUN_042019-T1,Peve_00044153,Pocillopora_meandrina_HIv1___RNAseq.g15192.t1,three_way,80.45633333333333,FUN_042019-T1,Q9DAN9,,,,,37.8,148.0,6.900000000000001e-23,109.0,sp|Q9DAN9|CF97D_MOUSE Sperm axonemal maintenance protein CFAP97D1 OS=Mus musculus OX=10090 GN=Cfap97d1 PE=2 SV=1,,,,,,
OG_09753,0.2191970839860489,FUN_042023-T1,Peve_00044157,Pocillopora_meandrina_HIv1___RNAseq.g15167.t1,three_way,91.09866666666666,FUN_042023-T1,Q0V9R4,,,,,42.4,877.0,1.1e-163,578.9,sp|Q0V9R4|CCD39_XENTR Coiled-coil domain-containing protein 39 OS=Xenopus tropicalis OX=8364 GN=ccdc39 PE=2 SV=1,,,,,,
OG_09845,0.2553029421196019,FUN_042830-T1,Peve_00041826,Pocillopora_meandrina_HIv1___RNAseq.g7271.t1,three_way,92.688,FUN_042830-T1,P62915,TF2B_MOUSE,,Transcription initiation factor IIB (EC 2.3.1.48) (General transcription factor TFIIB) (RNA polymerase II alpha initiation factor),Mus musculus (Mouse),79.1,316.0,4.3e-135,482.3,sp|P62915|TF2B_MOUSE Transcription initiation factor IIB OS=Mus musculus OX=10090 GN=Gtf2b PE=1 SV=1,GO:0000776; GO:0000793; GO:0000979; GO:0000993; GO:0001174; GO:0003677; GO:0004402; GO:0005634; GO:0005669; GO:0005694; GO:0006366; GO:0006367; GO:0006473; GO:0008270; GO:0010467; GO:0016251; GO:0016407; GO:0016604; GO:0017025; GO:0019083; GO:0032153; GO:0032993; GO:0042585; GO:0046966; GO:0051123; GO:0051177; GO:0051225; GO:0051276; GO:1990114; GO:1990841,chromosome organization [GO:0051276]; gene expression [GO:0010467]; meiotic sister chromatid cohesion [GO:0051177]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II preinitiation complex assembly [GO:0051123]; spindle assembly [GO:0051225]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; viral transcription [GO:0019083],cell division site [GO:0032153]; chromosome [GO:0005694]; condensed chromosome [GO:0000793]; germinal vesicle [GO:0042585]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription factor TFIID complex [GO:0005669],acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; nuclear thyroid hormone receptor binding [GO:0046966]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005694; GO:0006351; GO:0007010; GO:0016740; GO:0043226; GO:0065003; GO:0140096; GO:0140223,"DNA binding; catalytic activity; nucleus; chromosome; DNA-templated transcription; cytoskeleton organization; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on a protein; general transcription initiation factor activity"
OG_09847,0.339688774352744,FUN_042837-T1,Peve_00007263,Pocillopora_meandrina_HIv1___RNAseq.g7264.t1,three_way,78.92983333333333,FUN_042837-T1,Q32S26,BRD2_BOVIN,,Bromodomain-containing protein 2,Bos taurus (Bovine),50.9,737.0,1.5e-137,492.3,sp|Q32S26|BRD2_BOVIN Bromodomain-containing protein 2 OS=Bos taurus OX=9913 GN=BRD2 PE=3 SV=1,GO:0000785; GO:0005634; GO:0006334; GO:0006338; GO:0006355; GO:0006357; GO:0070577; GO:0071168; GO:0140012; GO:0140588; GO:2000330,chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; nucleosome assembly [GO:0006334]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; protein localization to chromatin [GO:0071168]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],histone H4K5ac reader activity [GO:0140012]; lysine-acetylated histone binding [GO:0070577],GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0065003,nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; protein-containing complex assembly
OG_09886,0.1650976659665541,FUN_042959-T1,Peve_00039053,Pocillopora_meandrina_HIv1___RNAseq.g7120.t1,three_way,63.528,FUN_042959-T1,B8PYG1,NSMF_DANRE,,NMDA receptor synaptonuclear signaling and neuronal migration factor (Nasal embryonic luteinizing hormone-releasing hormone factor) (Nasal embryonic LHRH factor),Danio rerio (Zebrafish) (Brachydanio rerio),33.0,221.0,3.7e-32,141.0,sp|B8PYG1|NSMF_DANRE NMDA receptor synaptonuclear signaling and neuronal migration factor OS=Danio rerio OX=7955 GN=nsmf PE=2 SV=1,GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005938; GO:0014069; GO:0016363; GO:0030425; GO:0031965; GO:0045773; GO:0048168; GO:2001224,positive regulation of axon extension [GO:0045773]; positive regulation of neuron migration [GO:2001224]; regulation of neuronal synaptic plasticity [GO:0048168],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],,GO:0005634; GO:0005856; GO:0005886; GO:0043226,nucleus; cytoskeleton; plasma membrane; organelle
OG_09970,0.0738398326139626,FUN_043152-T1,Peve_00011385,Pocillopora_meandrina_HIv1___TS.g568.t1,three_way,62.409,FUN_043152-T1,C3ZQF9,,,,,28.2,287.0,3.8e-20,100.5,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_09974,0.2503430842915023,FUN_043158-T1,Peve_00011401,Pocillopora_meandrina_HIv1___RNAseq.g6840.t1,three_way,89.59033333333333,FUN_043158-T1,A0A087WRI3,CFA77_MOUSE,,Cilia- and flagella-associated protein 77,Mus musculus (Mouse),37.8,238.0,7.1e-40,165.6,sp|A0A087WRI3|CFA77_MOUSE Cilia- and flagella-associated protein 77 OS=Mus musculus OX=10090 GN=Cfap77 PE=1 SV=1,GO:0030317; GO:0036126; GO:0160112,flagellated sperm motility [GO:0030317],axonemal B tubule inner sheath [GO:0160112]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_10164,0.4442546701205676,FUN_043563-T1,Peve_00008973,Pocillopora_meandrina_HIv1___RNAseq.g8051.t1,three_way,64.55266666666667,FUN_043563-T1,P53812,PIPNB_RAT,,Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta),Rattus norvegicus (Rat),55.7,264.0,4.7e-75,283.1,sp|P53812|PIPNB_RAT Phosphatidylinositol transfer protein beta isoform OS=Rattus norvegicus OX=10116 GN=Pitpnb PE=1 SV=2,GO:0000139; GO:0001701; GO:0005737; GO:0005789; GO:0005794; GO:0006890; GO:0008525; GO:0008526; GO:0015914; GO:0031210; GO:0035091; GO:0120019; GO:0140338,"in utero embryonic development [GO:0001701]; phospholipid transport [GO:0015914]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; sphingomyelin transfer activity [GO:0140338],GO:0005215; GO:0005794; GO:0008289; GO:0016192; GO:0043226; GO:0048856,transporter activity; Golgi apparatus; lipid binding; vesicle-mediated transport; organelle; anatomical structure development
